Gene Symbol | Gene ID | Gene Info |
---|---|---|
PLAGL1
|
ENSG00000118495.14 | PLAG1 like zinc finger 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr6_144292713_144292864 | PLAGL1 | 2673 | 0.370002 | -0.84 | 4.8e-03 | Click! |
chr6_144386506_144386657 | PLAGL1 | 846 | 0.683400 | 0.83 | 5.8e-03 | Click! |
chr6_144388201_144388461 | PLAGL1 | 2596 | 0.334402 | 0.81 | 8.2e-03 | Click! |
chr6_144328201_144328619 | PLAGL1 | 988 | 0.667029 | 0.78 | 1.3e-02 | Click! |
chr6_144376532_144376934 | PLAGL1 | 9002 | 0.247275 | 0.77 | 1.6e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr21_45576719_45576946 | 3.59 |
AP001055.1 |
|
16748 |
0.13 |
chr5_175956521_175957004 | 3.30 |
RNF44 |
ring finger protein 44 |
884 |
0.47 |
chr19_39369157_39369690 | 2.99 |
RINL |
Ras and Rab interactor-like |
504 |
0.57 |
chr11_2321744_2322272 | 2.46 |
C11orf21 |
chromosome 11 open reading frame 21 |
1135 |
0.3 |
chr20_37432775_37433181 | 2.44 |
PPP1R16B |
protein phosphatase 1, regulatory subunit 16B |
1370 |
0.43 |
chr11_2488116_2488649 | 2.43 |
KCNQ1 |
potassium voltage-gated channel, KQT-like subfamily, member 1 |
5265 |
0.19 |
chr3_52739214_52739466 | 2.40 |
SPCS1 |
signal peptidase complex subunit 1 homolog (S. cerevisiae) |
312 |
0.45 |
chr16_68109101_68109477 | 2.29 |
NFATC3 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3 |
9958 |
0.1 |
chr11_2322362_2322574 | 2.24 |
C11orf21 |
chromosome 11 open reading frame 21 |
675 |
0.42 |
chr11_2320203_2320640 | 2.16 |
C11orf21 |
chromosome 11 open reading frame 21 |
2722 |
0.17 |
chr17_19036587_19036921 | 2.15 |
GRAPL |
GRB2-related adaptor protein-like |
722 |
0.45 |
chr14_24837393_24837740 | 2.12 |
NFATC4 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4 |
19 |
0.94 |
chr16_57166733_57166910 | 2.12 |
CPNE2 |
copine II |
13710 |
0.14 |
chr22_50752388_50752886 | 2.09 |
XX-C283C717.1 |
|
423 |
0.69 |
chr7_99764513_99764874 | 2.09 |
GAL3ST4 |
galactose-3-O-sulfotransferase 4 |
160 |
0.86 |
chr1_204430993_204431895 | 2.08 |
PIK3C2B |
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 beta |
5030 |
0.21 |
chr21_45577023_45577427 | 2.06 |
AP001055.1 |
|
16355 |
0.13 |
chr14_73525713_73526043 | 2.05 |
RBM25 |
RNA binding motif protein 25 |
502 |
0.78 |
chr1_95699814_95699965 | 2.05 |
RWDD3 |
RWD domain containing 3 |
122 |
0.77 |
chr5_177665749_177666095 | 2.03 |
PHYKPL |
5-phosphohydroxy-L-lysine phospho-lyase |
6136 |
0.21 |
chr3_13024430_13024661 | 2.01 |
IQSEC1 |
IQ motif and Sec7 domain 1 |
3991 |
0.31 |
chr17_80259593_80259778 | 2.00 |
CD7 |
CD7 molecule |
15743 |
0.1 |
chr11_1873282_1874046 | 2.00 |
LSP1 |
lymphocyte-specific protein 1 |
536 |
0.61 |
chr12_132859595_132859799 | 1.95 |
RP13-895J2.3 |
|
5762 |
0.18 |
chr17_1084037_1084305 | 1.93 |
ABR |
active BCR-related |
1003 |
0.38 |
chr22_17597863_17598182 | 1.90 |
CECR6 |
cat eye syndrome chromosome region, candidate 6 |
4121 |
0.17 |
chr17_40827970_40828303 | 1.90 |
PLEKHH3 |
pleckstrin homology domain containing, family H (with MyTH4 domain) member 3 |
833 |
0.38 |
chr10_73494821_73495244 | 1.88 |
C10orf105 |
chromosome 10 open reading frame 105 |
2549 |
0.3 |
chr21_46332323_46332721 | 1.83 |
ITGB2 |
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
1147 |
0.33 |
chr6_33882815_33883519 | 1.82 |
ENSG00000221697 |
. |
84661 |
0.08 |
chr5_177543276_177543552 | 1.82 |
N4BP3 |
NEDD4 binding protein 3 |
2970 |
0.23 |
chr6_167460082_167460376 | 1.81 |
FGFR1OP |
FGFR1 oncogene partner |
47333 |
0.1 |
chr19_11564817_11564968 | 1.81 |
ENSG00000265149 |
. |
13199 |
0.08 |
chr1_54941539_54941789 | 1.80 |
ENSG00000265404 |
. |
28677 |
0.16 |
chr16_28304841_28305136 | 1.80 |
SBK1 |
SH3 domain binding kinase 1 |
1148 |
0.52 |
chr22_42695306_42695687 | 1.79 |
TCF20 |
transcription factor 20 (AR1) |
44126 |
0.14 |
chr7_2739159_2739434 | 1.79 |
AMZ1 |
archaelysin family metallopeptidase 1 |
11460 |
0.21 |
chr9_130330157_130330567 | 1.78 |
FAM129B |
family with sequence similarity 129, member B |
1005 |
0.52 |
chr16_88545798_88545998 | 1.77 |
ENSG00000263456 |
. |
10572 |
0.17 |
chr19_16488200_16488421 | 1.77 |
EPS15L1 |
epidermal growth factor receptor pathway substrate 15-like 1 |
15546 |
0.14 |
chr1_1148836_1149071 | 1.77 |
TNFRSF4 |
tumor necrosis factor receptor superfamily, member 4 |
559 |
0.53 |
chr11_1909959_1910419 | 1.76 |
C11orf89 |
chromosome 11 open reading frame 89 |
1895 |
0.19 |
chr17_76254387_76254694 | 1.76 |
TMEM235 |
transmembrane protein 235 |
26418 |
0.12 |
chr2_113931023_113931259 | 1.75 |
PSD4 |
pleckstrin and Sec7 domain containing 4 |
407 |
0.76 |
chr10_73495294_73495587 | 1.75 |
C10orf105 |
chromosome 10 open reading frame 105 |
2141 |
0.34 |
chr2_233185795_233185978 | 1.75 |
DIS3L2 |
DIS3 mitotic control homolog (S. cerevisiae)-like 2 |
12767 |
0.18 |
chr11_1911048_1911370 | 1.74 |
C11orf89 |
chromosome 11 open reading frame 89 |
875 |
0.42 |
chr16_50717313_50717932 | 1.73 |
SNX20 |
sorting nexin 20 |
2358 |
0.19 |
chr7_2739468_2739742 | 1.72 |
AMZ1 |
archaelysin family metallopeptidase 1 |
11769 |
0.21 |
chr1_2485967_2486421 | 1.72 |
TNFRSF14 |
tumor necrosis factor receptor superfamily, member 14 |
884 |
0.38 |
chr1_26861688_26862188 | 1.71 |
RPS6KA1 |
ribosomal protein S6 kinase, 90kDa, polypeptide 1 |
4119 |
0.17 |
chr15_91446650_91446801 | 1.70 |
MAN2A2 |
mannosidase, alpha, class 2A, member 2 |
249 |
0.84 |
chr16_88766525_88766822 | 1.70 |
RNF166 |
ring finger protein 166 |
209 |
0.83 |
chr11_67042287_67042439 | 1.70 |
ADRBK1 |
adrenergic, beta, receptor kinase 1 |
8411 |
0.11 |
chr11_67173204_67173355 | 1.69 |
TBC1D10C |
TBC1 domain family, member 10C |
1619 |
0.15 |
chr16_29675395_29675762 | 1.69 |
QPRT |
quinolinate phosphoribosyltransferase |
978 |
0.33 |
chr17_19035496_19035720 | 1.68 |
GRAPL |
GRB2-related adaptor protein-like |
242 |
0.84 |
chr20_62475797_62476005 | 1.68 |
AL158091.1 |
Protein LOC100509861 |
628 |
0.51 |
chr19_55765960_55766111 | 1.68 |
PPP6R1 |
protein phosphatase 6, regulatory subunit 1 |
1102 |
0.28 |
chr11_67178704_67178855 | 1.68 |
CARNS1 |
carnosine synthase 1 |
4370 |
0.08 |
chr5_176857919_176858519 | 1.65 |
GRK6 |
G protein-coupled receptor kinase 6 |
4364 |
0.11 |
chr20_23401674_23401825 | 1.65 |
NAPB |
N-ethylmaleimide-sensitive factor attachment protein, beta |
349 |
0.81 |
chr19_42702815_42703281 | 1.65 |
ENSG00000265122 |
. |
5818 |
0.1 |
chr17_79420586_79420890 | 1.64 |
ENSG00000266189 |
. |
2524 |
0.16 |
chr14_93081555_93081992 | 1.62 |
RIN3 |
Ras and Rab interactor 3 |
37073 |
0.2 |
chr1_43417564_43417791 | 1.62 |
SLC2A1 |
solute carrier family 2 (facilitated glucose transporter), member 1 |
6823 |
0.19 |
chr17_3818217_3818504 | 1.62 |
P2RX1 |
purinergic receptor P2X, ligand-gated ion channel, 1 |
1434 |
0.36 |
chr19_4083978_4084223 | 1.62 |
MAP2K2 |
mitogen-activated protein kinase kinase 2 |
16945 |
0.1 |
chr1_23810120_23810354 | 1.62 |
ASAP3 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain 3 |
434 |
0.83 |
chr19_42463079_42463289 | 1.62 |
RABAC1 |
Rab acceptor 1 (prenylated) |
118 |
0.95 |
chr5_98106280_98106431 | 1.62 |
RGMB |
repulsive guidance molecule family member b |
1356 |
0.43 |
chr22_38071514_38071665 | 1.62 |
LGALS1 |
lectin, galactoside-binding, soluble, 1 |
26 |
0.95 |
chr8_126518452_126518899 | 1.61 |
ENSG00000266452 |
. |
61868 |
0.13 |
chr2_96824462_96824613 | 1.61 |
DUSP2 |
dual specificity phosphatase 2 |
13358 |
0.14 |
chr20_55976055_55976264 | 1.60 |
RP4-800J21.3 |
|
8041 |
0.16 |
chr1_25311224_25311505 | 1.60 |
RUNX3 |
runt-related transcription factor 3 |
19863 |
0.18 |
chr8_144655209_144655539 | 1.59 |
MROH6 |
maestro heat-like repeat family member 6 |
233 |
0.51 |
chr1_28586799_28587133 | 1.59 |
SESN2 |
sestrin 2 |
928 |
0.45 |
chr21_44835236_44835488 | 1.59 |
SIK1 |
salt-inducible kinase 1 |
11646 |
0.28 |
chr17_37250282_37250699 | 1.59 |
ENSG00000222494 |
. |
13172 |
0.14 |
chr21_46338196_46338426 | 1.59 |
ITGB2 |
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
2459 |
0.16 |
chr3_13057227_13057378 | 1.59 |
IQSEC1 |
IQ motif and Sec7 domain 1 |
28766 |
0.23 |
chr16_88768919_88769359 | 1.59 |
RNF166 |
ring finger protein 166 |
886 |
0.31 |
chr4_2293050_2293361 | 1.59 |
ZFYVE28 |
zinc finger, FYVE domain containing 28 |
3763 |
0.15 |
chr15_78395422_78395756 | 1.58 |
SH2D7 |
SH2 domain containing 7 |
10662 |
0.13 |
chr12_131995509_131995912 | 1.57 |
ENSG00000212154 |
. |
149898 |
0.04 |
chr20_62668233_62668488 | 1.57 |
ZNF512B |
zinc finger protein 512B |
1578 |
0.21 |
chr6_167534419_167534775 | 1.56 |
CCR6 |
chemokine (C-C motif) receptor 6 |
1660 |
0.37 |
chrX_153582032_153582208 | 1.56 |
FLNA |
filamin A, alpha |
583 |
0.57 |
chr2_113937603_113937798 | 1.56 |
AC016683.5 |
|
4763 |
0.16 |
chr19_47290243_47290479 | 1.56 |
SLC1A5 |
solute carrier family 1 (neutral amino acid transporter), member 5 |
238 |
0.89 |
chr17_80187474_80187768 | 1.56 |
SLC16A3 |
solute carrier family 16 (monocarboxylate transporter), member 3 |
652 |
0.55 |
chr11_67046241_67046409 | 1.56 |
ANKRD13D |
ankyrin repeat domain 13 family, member D |
9693 |
0.11 |
chr9_92097148_92097521 | 1.56 |
SEMA4D |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D |
2529 |
0.33 |
chr16_29164996_29165147 | 1.56 |
CTB-134H23.3 |
|
46305 |
0.11 |
chr5_11233980_11234297 | 1.55 |
ENSG00000207312 |
. |
206826 |
0.03 |
chr14_102063212_102063453 | 1.54 |
DIO3 |
deiodinase, iodothyronine, type III |
35644 |
0.15 |
chr8_142414415_142414628 | 1.53 |
CTD-3064M3.4 |
|
11847 |
0.12 |
chr1_1140948_1141273 | 1.53 |
TNFRSF18 |
tumor necrosis factor receptor superfamily, member 18 |
50 |
0.93 |
chr17_80259260_80259561 | 1.53 |
CD7 |
CD7 molecule |
16018 |
0.1 |
chr1_1951537_1951716 | 1.53 |
GABRD |
gamma-aminobutyric acid (GABA) A receptor, delta |
846 |
0.49 |
chr16_88766157_88766414 | 1.53 |
RNF166 |
ring finger protein 166 |
171 |
0.86 |
chr20_31560402_31560699 | 1.52 |
EFCAB8 |
EF-hand calcium binding domain 8 |
12899 |
0.15 |
chr2_101171269_101171480 | 1.52 |
ENSG00000266005 |
. |
1138 |
0.46 |
chr1_9687682_9687977 | 1.51 |
PIK3CD |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta |
23961 |
0.14 |
chr16_30671534_30671721 | 1.51 |
FBRS |
fibrosin |
384 |
0.7 |
chr6_35279762_35280244 | 1.51 |
DEF6 |
differentially expressed in FDCP 6 homolog (mouse) |
2488 |
0.27 |
chr10_134429030_134429352 | 1.50 |
INPP5A |
inositol polyphosphate-5-phosphatase, 40kDa |
7761 |
0.27 |
chr19_6424039_6424190 | 1.50 |
KHSRP |
KH-type splicing regulatory protein |
174 |
0.88 |
chr10_126300000_126300388 | 1.49 |
FAM53B-AS1 |
FAM53B antisense RNA 1 |
92000 |
0.07 |
chr19_10663855_10664009 | 1.49 |
ENSG00000221410 |
. |
1134 |
0.23 |
chr19_14228029_14228210 | 1.49 |
PRKACA |
protein kinase, cAMP-dependent, catalytic, alpha |
425 |
0.67 |
chr9_126138722_126138873 | 1.49 |
CRB2 |
crumbs homolog 2 (Drosophila) |
7629 |
0.23 |
chr17_76121997_76122236 | 1.49 |
TMC6 |
transmembrane channel-like 6 |
985 |
0.4 |
chr9_132630795_132631295 | 1.49 |
USP20 |
ubiquitin specific peptidase 20 |
33288 |
0.12 |
chr9_126102506_126102867 | 1.49 |
CRB2 |
crumbs homolog 2 (Drosophila) |
15763 |
0.22 |
chr7_45016076_45016453 | 1.49 |
MYO1G |
myosin IG |
2433 |
0.2 |
chr17_8844881_8845564 | 1.48 |
PIK3R5 |
phosphoinositide-3-kinase, regulatory subunit 5 |
23802 |
0.21 |
chr11_60849797_60850034 | 1.48 |
CD5 |
CD5 molecule |
19952 |
0.16 |
chr9_140282226_140282466 | 1.47 |
ENSG00000272272 |
. |
33250 |
0.09 |
chr17_72753486_72753694 | 1.47 |
SLC9A3R1 |
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 1 |
4552 |
0.11 |
chr10_133973135_133973286 | 1.47 |
RP11-140A10.3 |
|
25293 |
0.18 |
chr12_7067049_7067256 | 1.47 |
ENSG00000207713 |
. |
5710 |
0.06 |
chr14_102002023_102002232 | 1.47 |
ENSG00000258498 |
. |
24632 |
0.17 |
chr9_134460225_134460628 | 1.46 |
RAPGEF1 |
Rap guanine nucleotide exchange factor (GEF) 1 |
36799 |
0.13 |
chr19_54871568_54871766 | 1.46 |
LAIR1 |
leukocyte-associated immunoglobulin-like receptor 1 |
889 |
0.43 |
chr11_117886387_117886681 | 1.46 |
IL10RA |
interleukin 10 receptor, alpha |
29425 |
0.14 |
chr11_46367187_46367549 | 1.44 |
DGKZ |
diacylglycerol kinase, zeta |
381 |
0.82 |
chr14_105532821_105533069 | 1.44 |
GPR132 |
G protein-coupled receptor 132 |
1163 |
0.49 |
chr19_13993263_13993689 | 1.44 |
NANOS3 |
nanos homolog 3 (Drosophila) |
5413 |
0.09 |
chr11_67177124_67177505 | 1.43 |
TBC1D10C |
TBC1 domain family, member 10C |
5654 |
0.07 |
chr19_14094328_14094893 | 1.43 |
RFX1 |
regulatory factor X, 1 (influences HLA class II expression) |
22464 |
0.09 |
chr11_69456900_69457051 | 1.43 |
CCND1 |
cyclin D1 |
1001 |
0.59 |
chr7_6663355_6663506 | 1.43 |
ZNF853 |
zinc finger protein 853 |
8182 |
0.13 |
chr8_42188476_42188627 | 1.43 |
POLB |
polymerase (DNA directed), beta |
7421 |
0.18 |
chr18_60825707_60826108 | 1.43 |
RP11-299P2.1 |
|
7354 |
0.25 |
chr19_46295408_46295559 | 1.43 |
DMWD |
dystrophia myotonica, WD repeat containing |
212 |
0.85 |
chr11_68038659_68039198 | 1.43 |
C11orf24 |
chromosome 11 open reading frame 24 |
487 |
0.82 |
chr14_93500721_93500992 | 1.43 |
ITPK1 |
inositol-tetrakisphosphate 1-kinase |
31847 |
0.17 |
chr2_16105641_16106067 | 1.42 |
ENSG00000243541 |
. |
14751 |
0.18 |
chr7_156932251_156932402 | 1.42 |
UBE3C |
ubiquitin protein ligase E3C |
437 |
0.86 |
chr1_68298304_68298660 | 1.42 |
GNG12-AS1 |
GNG12 antisense RNA 1 |
490 |
0.57 |
chr16_691369_691551 | 1.42 |
FAM195A |
family with sequence similarity 195, member A |
353 |
0.64 |
chr10_126850115_126850433 | 1.42 |
CTBP2 |
C-terminal binding protein 2 |
644 |
0.82 |
chr11_61100062_61100329 | 1.42 |
DDB1 |
damage-specific DNA binding protein 1, 127kDa |
112 |
0.84 |
chr20_61636476_61636627 | 1.41 |
BHLHE23 |
basic helix-loop-helix family, member e23 |
1836 |
0.33 |
chr11_1568905_1569175 | 1.41 |
DUSP8 |
dual specificity phosphatase 8 |
18126 |
0.12 |
chr3_13388429_13388737 | 1.41 |
NUP210 |
nucleoporin 210kDa |
73226 |
0.11 |
chr12_7067345_7067996 | 1.41 |
ENSG00000207713 |
. |
5192 |
0.06 |
chr16_3057668_3058079 | 1.41 |
LA16c-380H5.2 |
|
2771 |
0.09 |
chr11_2320673_2321045 | 1.41 |
C11orf21 |
chromosome 11 open reading frame 21 |
2284 |
0.19 |
chr2_98334776_98334948 | 1.40 |
ZAP70 |
zeta-chain (TCR) associated protein kinase 70kDa |
4839 |
0.19 |
chr1_43396254_43396405 | 1.40 |
SLC2A1 |
solute carrier family 2 (facilitated glucose transporter), member 1 |
467 |
0.82 |
chr15_31557369_31557520 | 1.40 |
KLF13 |
Kruppel-like factor 13 |
61614 |
0.14 |
chr9_134134182_134134333 | 1.39 |
FAM78A |
family with sequence similarity 78, member A |
11623 |
0.17 |
chr19_45350688_45350898 | 1.39 |
PVRL2 |
poliovirus receptor-related 2 (herpesvirus entry mediator B) |
1010 |
0.39 |
chr19_45668417_45668581 | 1.39 |
NKPD1 |
NTPase, KAP family P-loop domain containing 1 |
5091 |
0.11 |
chr11_1777921_1778072 | 1.39 |
CTSD |
cathepsin D |
1820 |
0.16 |
chr8_38325731_38325987 | 1.39 |
FGFR1 |
fibroblast growth factor receptor 1 |
275 |
0.9 |
chrY_1533200_1533719 | 1.39 |
NA |
NA |
> 106 |
NA |
chr20_17592532_17592683 | 1.38 |
ENSG00000202260 |
. |
35452 |
0.13 |
chr16_88765577_88765835 | 1.38 |
RNF166 |
ring finger protein 166 |
408 |
0.63 |
chr13_114909698_114910252 | 1.38 |
RASA3 |
RAS p21 protein activator 3 |
11889 |
0.21 |
chr9_117132575_117132773 | 1.38 |
AKNA |
AT-hook transcription factor |
6570 |
0.21 |
chr10_3462374_3462591 | 1.38 |
PITRM1 |
pitrilysin metallopeptidase 1 |
247479 |
0.02 |
chr3_13111271_13111777 | 1.38 |
IQSEC1 |
IQ motif and Sec7 domain 1 |
3093 |
0.38 |
chr4_1753783_1753977 | 1.38 |
TACC3 |
transforming, acidic coiled-coil containing protein 3 |
23749 |
0.13 |
chr3_66023505_66023773 | 1.38 |
MAGI1 |
membrane associated guanylate kinase, WW and PDZ domain containing 1 |
344 |
0.9 |
chr1_206734149_206734498 | 1.38 |
RASSF5 |
Ras association (RalGDS/AF-6) domain family member 5 |
3830 |
0.2 |
chr1_27160442_27160760 | 1.38 |
ZDHHC18 |
zinc finger, DHHC-type containing 18 |
2090 |
0.2 |
chr1_182360343_182360566 | 1.38 |
GLUL |
glutamate-ammonia ligase |
85 |
0.97 |
chr9_92153229_92153575 | 1.37 |
SEMA4D |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D |
40357 |
0.16 |
chr10_130856557_130857124 | 1.37 |
MGMT |
O-6-methylguanine-DNA methyltransferase |
408608 |
0.01 |
chr19_55020227_55020521 | 1.37 |
LAIR2 |
leukocyte-associated immunoglobulin-like receptor 2 |
6251 |
0.11 |
chr16_3070538_3070989 | 1.37 |
TNFRSF12A |
tumor necrosis factor receptor superfamily, member 12A |
383 |
0.5 |
chr14_91783405_91783878 | 1.36 |
ENSG00000265856 |
. |
16416 |
0.19 |
chr18_74765879_74766101 | 1.36 |
MBP |
myelin basic protein |
36256 |
0.2 |
chr17_79261558_79261764 | 1.36 |
SLC38A10 |
solute carrier family 38, member 10 |
5597 |
0.14 |
chr17_75842366_75842622 | 1.36 |
FLJ45079 |
|
36165 |
0.19 |
chr14_104858810_104858961 | 1.36 |
ENSG00000222761 |
. |
8500 |
0.27 |
chr6_13428716_13429009 | 1.36 |
GFOD1 |
glucose-fructose oxidoreductase domain containing 1 |
20493 |
0.18 |
chr19_12832299_12832694 | 1.36 |
TNPO2 |
transportin 2 |
33 |
0.93 |
chr17_79318767_79318934 | 1.36 |
TMEM105 |
transmembrane protein 105 |
14376 |
0.13 |
chr14_91842844_91843127 | 1.36 |
CCDC88C |
coiled-coil domain containing 88C |
40705 |
0.15 |
chr14_105543973_105544183 | 1.36 |
GPR132 |
G protein-coupled receptor 132 |
12296 |
0.18 |
chr2_219269324_219269539 | 1.36 |
ENSG00000199121 |
. |
2062 |
0.17 |
chr18_77161709_77162041 | 1.36 |
NFATC1 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 |
1483 |
0.49 |
chr19_47226010_47226260 | 1.35 |
STRN4 |
striatin, calmodulin binding protein 4 |
333 |
0.76 |
chr22_19595594_19595745 | 1.35 |
CLDN5 |
claudin 5 |
80601 |
0.07 |
chr9_134127671_134127998 | 1.35 |
FAM78A |
family with sequence similarity 78, member A |
18046 |
0.15 |
chr7_150706994_150707399 | 1.35 |
NOS3 |
nitric oxide synthase 3 (endothelial cell) |
1171 |
0.31 |
chr8_144452193_144452436 | 1.35 |
RHPN1 |
rhophilin, Rho GTPase binding protein 1 |
1257 |
0.25 |
chr18_43924333_43924921 | 1.35 |
RNF165 |
ring finger protein 165 |
10440 |
0.28 |
chr10_134264591_134264838 | 1.35 |
C10orf91 |
chromosome 10 open reading frame 91 |
6021 |
0.19 |
chr8_67342216_67342464 | 1.35 |
ADHFE1 |
alcohol dehydrogenase, iron containing, 1 |
80 |
0.95 |
chr19_5131953_5132104 | 1.35 |
CTC-482H14.5 |
|
46102 |
0.14 |
chr17_56411702_56411930 | 1.35 |
ENSG00000264399 |
. |
1567 |
0.22 |
chr16_29756155_29756375 | 1.34 |
AC009133.17 |
|
303 |
0.74 |
chr6_35277788_35277984 | 1.34 |
DEF6 |
differentially expressed in FDCP 6 homolog (mouse) |
371 |
0.86 |
chr9_100937607_100937767 | 1.34 |
CORO2A |
coronin, actin binding protein, 2A |
2521 |
0.31 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.4 | 7.2 | GO:0030223 | neutrophil differentiation(GO:0030223) |
1.8 | 5.5 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
1.7 | 5.0 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
1.7 | 5.0 | GO:0018094 | protein polyglycylation(GO:0018094) |
1.5 | 1.5 | GO:0051155 | positive regulation of striated muscle cell differentiation(GO:0051155) |
1.5 | 7.4 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
1.4 | 7.2 | GO:0090205 | positive regulation of cholesterol metabolic process(GO:0090205) |
1.4 | 4.1 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
1.3 | 6.7 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
1.3 | 5.3 | GO:0032661 | interleukin-18 production(GO:0032621) regulation of interleukin-18 production(GO:0032661) |
1.3 | 1.3 | GO:0051928 | positive regulation of calcium ion transport(GO:0051928) |
1.2 | 3.7 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
1.2 | 4.9 | GO:0070141 | response to UV-A(GO:0070141) |
1.2 | 3.7 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
1.2 | 8.2 | GO:0045061 | thymic T cell selection(GO:0045061) |
1.2 | 4.6 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) |
1.1 | 6.7 | GO:0045588 | gamma-delta T cell differentiation(GO:0042492) regulation of gamma-delta T cell differentiation(GO:0045586) positive regulation of gamma-delta T cell differentiation(GO:0045588) regulation of gamma-delta T cell activation(GO:0046643) positive regulation of gamma-delta T cell activation(GO:0046645) |
1.1 | 3.3 | GO:0097576 | vacuole fusion(GO:0097576) |
1.1 | 3.2 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) glial cell fate specification(GO:0021780) |
1.0 | 2.1 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) |
1.0 | 3.1 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
1.0 | 7.1 | GO:0007172 | signal complex assembly(GO:0007172) |
1.0 | 3.1 | GO:0031558 | obsolete induction of apoptosis in response to chemical stimulus(GO:0031558) |
1.0 | 1.0 | GO:0071503 | response to heparin(GO:0071503) |
1.0 | 3.0 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
1.0 | 4.0 | GO:0000089 | mitotic metaphase(GO:0000089) |
1.0 | 3.0 | GO:0003077 | obsolete negative regulation of diuresis(GO:0003077) |
1.0 | 3.0 | GO:0072162 | mesenchymal cell differentiation involved in kidney development(GO:0072161) metanephric mesenchymal cell differentiation(GO:0072162) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
1.0 | 2.0 | GO:0072224 | metanephric glomerulus development(GO:0072224) metanephric glomerulus vasculature development(GO:0072239) |
1.0 | 3.9 | GO:0014805 | smooth muscle adaptation(GO:0014805) |
1.0 | 2.9 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
1.0 | 1.0 | GO:0035412 | catenin import into nucleus(GO:0035411) regulation of catenin import into nucleus(GO:0035412) |
1.0 | 2.9 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
1.0 | 2.9 | GO:0036037 | CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
1.0 | 1.0 | GO:0008347 | glial cell migration(GO:0008347) |
0.9 | 2.8 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.9 | 4.6 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.9 | 2.7 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.9 | 0.9 | GO:0048145 | regulation of fibroblast proliferation(GO:0048145) |
0.9 | 3.6 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.9 | 2.7 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.9 | 0.9 | GO:0060685 | regulation of prostatic bud formation(GO:0060685) |
0.9 | 1.8 | GO:0061054 | dermatome development(GO:0061054) |
0.9 | 1.7 | GO:0060242 | contact inhibition(GO:0060242) |
0.9 | 13.0 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.9 | 4.3 | GO:0033084 | regulation of immature T cell proliferation in thymus(GO:0033084) |
0.9 | 3.5 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.9 | 0.9 | GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway(GO:0031664) |
0.9 | 0.9 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.8 | 2.5 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
0.8 | 2.5 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.8 | 0.8 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.8 | 20.1 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.8 | 3.3 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.8 | 3.3 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.8 | 6.5 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.8 | 2.4 | GO:0043320 | natural killer cell activation involved in immune response(GO:0002323) natural killer cell degranulation(GO:0043320) |
0.8 | 8.8 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.8 | 2.4 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.8 | 0.8 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.8 | 2.4 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.8 | 4.8 | GO:0002063 | chondrocyte development(GO:0002063) |
0.8 | 3.9 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.8 | 2.3 | GO:0006154 | adenosine catabolic process(GO:0006154) |
0.8 | 1.6 | GO:0002513 | tolerance induction to self antigen(GO:0002513) |
0.8 | 3.1 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.8 | 2.3 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.8 | 2.3 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.8 | 0.8 | GO:0000255 | allantoin metabolic process(GO:0000255) creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
0.8 | 0.8 | GO:0060430 | lung saccule development(GO:0060430) Type II pneumocyte differentiation(GO:0060510) |
0.7 | 1.5 | GO:0002874 | chronic inflammatory response to antigenic stimulus(GO:0002439) regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
0.7 | 1.5 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.7 | 2.2 | GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002923) |
0.7 | 0.7 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.7 | 2.2 | GO:0090322 | regulation of superoxide metabolic process(GO:0090322) |
0.7 | 0.7 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.7 | 0.7 | GO:0006927 | obsolete transformed cell apoptotic process(GO:0006927) |
0.7 | 0.7 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.7 | 2.9 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.7 | 2.1 | GO:0050870 | positive regulation of T cell activation(GO:0050870) positive regulation of leukocyte cell-cell adhesion(GO:1903039) |
0.7 | 3.5 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.7 | 2.8 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.7 | 2.7 | GO:0001911 | negative regulation of leukocyte mediated cytotoxicity(GO:0001911) |
0.7 | 2.1 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.7 | 3.4 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.7 | 2.0 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.7 | 1.3 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.7 | 0.7 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.7 | 0.7 | GO:0046931 | pore complex assembly(GO:0046931) |
0.7 | 2.0 | GO:0045046 | protein import into peroxisome membrane(GO:0045046) |
0.7 | 2.0 | GO:1901534 | positive regulation of megakaryocyte differentiation(GO:0045654) positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.7 | 0.7 | GO:0003157 | endocardium development(GO:0003157) endocardium morphogenesis(GO:0003160) |
0.7 | 4.0 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.7 | 1.3 | GO:0006922 | obsolete cleavage of lamin involved in execution phase of apoptosis(GO:0006922) |
0.7 | 1.3 | GO:0003181 | atrioventricular valve development(GO:0003171) atrioventricular valve morphogenesis(GO:0003181) |
0.7 | 0.7 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.7 | 3.3 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.7 | 1.3 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
0.7 | 3.3 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.6 | 0.6 | GO:0051665 | membrane raft localization(GO:0051665) |
0.6 | 1.3 | GO:0051446 | positive regulation of meiotic nuclear division(GO:0045836) positive regulation of meiotic cell cycle(GO:0051446) |
0.6 | 1.9 | GO:0031100 | organ regeneration(GO:0031100) |
0.6 | 2.5 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
0.6 | 0.6 | GO:0002085 | inhibition of neuroepithelial cell differentiation(GO:0002085) |
0.6 | 3.1 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.6 | 1.2 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.6 | 31.8 | GO:0031295 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.6 | 0.6 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.6 | 0.6 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.6 | 3.0 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.6 | 0.6 | GO:0002507 | tolerance induction(GO:0002507) |
0.6 | 1.8 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.6 | 2.4 | GO:0000154 | rRNA modification(GO:0000154) |
0.6 | 1.8 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.6 | 1.2 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.6 | 1.8 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.6 | 2.4 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.6 | 0.6 | GO:0045909 | positive regulation of vasodilation(GO:0045909) |
0.6 | 1.8 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
0.6 | 1.8 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.6 | 6.4 | GO:0031648 | protein destabilization(GO:0031648) |
0.6 | 1.2 | GO:0033085 | negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
0.6 | 3.5 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.6 | 1.1 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.6 | 1.1 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) mature B cell differentiation(GO:0002335) |
0.6 | 3.4 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.6 | 0.6 | GO:0048664 | neuron fate determination(GO:0048664) |
0.6 | 2.3 | GO:0044803 | multi-organism membrane organization(GO:0044803) |
0.6 | 0.6 | GO:0007144 | female meiosis I(GO:0007144) |
0.6 | 0.6 | GO:0017085 | response to insecticide(GO:0017085) |
0.6 | 1.7 | GO:0003057 | regulation of the force of heart contraction by chemical signal(GO:0003057) |
0.6 | 2.2 | GO:0042441 | eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
0.6 | 2.2 | GO:0060251 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) regulation of glial cell proliferation(GO:0060251) negative regulation of glial cell proliferation(GO:0060253) |
0.6 | 2.8 | GO:0042634 | regulation of hair cycle(GO:0042634) |
0.6 | 0.6 | GO:0034625 | fatty acid elongation, monounsaturated fatty acid(GO:0034625) |
0.6 | 1.7 | GO:0046015 | carbon catabolite regulation of transcription(GO:0045990) regulation of transcription by glucose(GO:0046015) |
0.6 | 2.2 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.5 | 2.2 | GO:0072498 | embryonic skeletal joint morphogenesis(GO:0060272) embryonic skeletal joint development(GO:0072498) |
0.5 | 1.1 | GO:0090382 | phagolysosome assembly(GO:0001845) phagosome maturation(GO:0090382) |
0.5 | 2.2 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.5 | 1.6 | GO:0001961 | positive regulation of cytokine-mediated signaling pathway(GO:0001961) |
0.5 | 3.2 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.5 | 4.9 | GO:0045022 | early endosome to late endosome transport(GO:0045022) vesicle-mediated transport between endosomal compartments(GO:0098927) |
0.5 | 1.1 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
0.5 | 3.2 | GO:0045885 | obsolete positive regulation of survival gene product expression(GO:0045885) |
0.5 | 1.6 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.5 | 1.6 | GO:0090281 | negative regulation of calcium ion import(GO:0090281) |
0.5 | 1.6 | GO:0002823 | negative regulation of adaptive immune response(GO:0002820) negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains(GO:0002823) |
0.5 | 3.7 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.5 | 1.6 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.5 | 1.1 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.5 | 0.5 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.5 | 0.5 | GO:0002448 | mast cell mediated immunity(GO:0002448) |
0.5 | 1.1 | GO:0060437 | lung growth(GO:0060437) |
0.5 | 2.1 | GO:0019987 | obsolete negative regulation of anti-apoptosis(GO:0019987) |
0.5 | 3.7 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.5 | 0.5 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.5 | 0.5 | GO:0051321 | meiotic cell cycle(GO:0051321) |
0.5 | 1.6 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.5 | 0.5 | GO:0002467 | germinal center formation(GO:0002467) |
0.5 | 2.6 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.5 | 2.1 | GO:0031442 | positive regulation of mRNA 3'-end processing(GO:0031442) positive regulation of mRNA processing(GO:0050685) positive regulation of mRNA metabolic process(GO:1903313) |
0.5 | 1.0 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.5 | 4.1 | GO:0003407 | neural retina development(GO:0003407) |
0.5 | 0.5 | GO:0045625 | regulation of T-helper 1 cell differentiation(GO:0045625) |
0.5 | 1.5 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.5 | 0.5 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.5 | 4.1 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.5 | 14.8 | GO:0050772 | positive regulation of axonogenesis(GO:0050772) |
0.5 | 3.6 | GO:0050957 | equilibrioception(GO:0050957) |
0.5 | 1.0 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.5 | 0.5 | GO:0052251 | induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) |
0.5 | 0.5 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.5 | 2.5 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.5 | 1.0 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.5 | 4.0 | GO:1904031 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.5 | 1.0 | GO:0031057 | negative regulation of histone modification(GO:0031057) |
0.5 | 1.0 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.5 | 1.0 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.5 | 8.4 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
0.5 | 1.5 | GO:0031034 | skeletal muscle myosin thick filament assembly(GO:0030241) myosin filament organization(GO:0031033) myosin filament assembly(GO:0031034) striated muscle myosin thick filament assembly(GO:0071688) |
0.5 | 1.5 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.5 | 2.0 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.5 | 1.0 | GO:0051169 | nuclear transport(GO:0051169) |
0.5 | 4.9 | GO:0000303 | response to superoxide(GO:0000303) |
0.5 | 2.9 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.5 | 0.5 | GO:0048069 | eye pigmentation(GO:0048069) |
0.5 | 0.5 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.5 | 2.4 | GO:0002329 | immature B cell differentiation(GO:0002327) pre-B cell differentiation(GO:0002329) |
0.5 | 1.5 | GO:0051532 | NFAT protein import into nucleus(GO:0051531) regulation of NFAT protein import into nucleus(GO:0051532) |
0.5 | 1.9 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.5 | 1.4 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.5 | 1.0 | GO:0019724 | B cell mediated immunity(GO:0019724) |
0.5 | 0.5 | GO:0034765 | regulation of ion transmembrane transport(GO:0034765) |
0.5 | 4.3 | GO:0042354 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.5 | 2.4 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.5 | 1.4 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.5 | 0.5 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.5 | 0.5 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.5 | 1.9 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.5 | 1.4 | GO:0090201 | negative regulation of mitochondrion organization(GO:0010823) negative regulation of release of cytochrome c from mitochondria(GO:0090201) negative regulation of apoptotic signaling pathway(GO:2001234) |
0.5 | 3.3 | GO:0050856 | regulation of T cell receptor signaling pathway(GO:0050856) |
0.5 | 0.5 | GO:0048634 | regulation of muscle organ development(GO:0048634) |
0.5 | 2.8 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.5 | 8.8 | GO:0045576 | mast cell activation(GO:0045576) |
0.5 | 1.8 | GO:0001553 | luteinization(GO:0001553) |
0.5 | 0.9 | GO:0071674 | regulation of macrophage chemotaxis(GO:0010758) positive regulation of macrophage chemotaxis(GO:0010759) mononuclear cell migration(GO:0071674) regulation of mononuclear cell migration(GO:0071675) |
0.5 | 0.5 | GO:0002634 | regulation of germinal center formation(GO:0002634) |
0.5 | 1.4 | GO:0090399 | replicative senescence(GO:0090399) |
0.5 | 3.6 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.5 | 1.4 | GO:0042345 | regulation of NF-kappaB import into nucleus(GO:0042345) NF-kappaB import into nucleus(GO:0042348) |
0.5 | 0.9 | GO:1901797 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) negative regulation of signal transduction by p53 class mediator(GO:1901797) |
0.5 | 6.8 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.4 | 3.6 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.4 | 0.9 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.4 | 2.7 | GO:0032735 | positive regulation of interleukin-12 production(GO:0032735) |
0.4 | 2.2 | GO:0033261 | obsolete regulation of S phase(GO:0033261) |
0.4 | 1.3 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.4 | 1.3 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.4 | 4.5 | GO:0001706 | endoderm formation(GO:0001706) |
0.4 | 4.0 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.4 | 0.9 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.4 | 1.8 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
0.4 | 0.4 | GO:0019674 | NAD metabolic process(GO:0019674) |
0.4 | 3.1 | GO:0008653 | lipopolysaccharide metabolic process(GO:0008653) |
0.4 | 1.3 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.4 | 1.3 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.4 | 1.8 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.4 | 0.9 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.4 | 0.4 | GO:0090009 | primitive streak formation(GO:0090009) |
0.4 | 0.4 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) DNA replication, removal of RNA primer(GO:0043137) |
0.4 | 0.9 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.4 | 1.3 | GO:0030186 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.4 | 1.7 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.4 | 1.3 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.4 | 2.6 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.4 | 1.7 | GO:0060122 | inner ear receptor stereocilium organization(GO:0060122) |
0.4 | 2.2 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.4 | 0.9 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
0.4 | 0.4 | GO:0043113 | receptor clustering(GO:0043113) |
0.4 | 1.7 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.4 | 0.4 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
0.4 | 1.3 | GO:1904019 | endothelial cell apoptotic process(GO:0072577) epithelial cell apoptotic process(GO:1904019) regulation of epithelial cell apoptotic process(GO:1904035) regulation of endothelial cell apoptotic process(GO:2000351) |
0.4 | 0.4 | GO:0051877 | pigment granule aggregation in cell center(GO:0051877) |
0.4 | 0.8 | GO:0022605 | oogenesis stage(GO:0022605) |
0.4 | 1.2 | GO:0035268 | protein mannosylation(GO:0035268) protein O-linked mannosylation(GO:0035269) mannosylation(GO:0097502) |
0.4 | 0.4 | GO:0002691 | regulation of cellular extravasation(GO:0002691) |
0.4 | 1.7 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.4 | 1.2 | GO:0072583 | synaptic vesicle recycling(GO:0036465) synaptic vesicle endocytosis(GO:0048488) clathrin-mediated endocytosis(GO:0072583) |
0.4 | 4.1 | GO:0000085 | mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
0.4 | 1.2 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.4 | 0.4 | GO:0010629 | negative regulation of gene expression(GO:0010629) |
0.4 | 2.4 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.4 | 0.4 | GO:0031646 | positive regulation of neurological system process(GO:0031646) positive regulation of transmission of nerve impulse(GO:0051971) |
0.4 | 1.6 | GO:0003351 | epithelial cilium movement(GO:0003351) epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.4 | 0.4 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.4 | 1.2 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.4 | 0.8 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.4 | 0.4 | GO:0032060 | bleb assembly(GO:0032060) |
0.4 | 0.8 | GO:0010586 | miRNA metabolic process(GO:0010586) miRNA catabolic process(GO:0010587) |
0.4 | 0.8 | GO:0021801 | cerebral cortex radial glia guided migration(GO:0021801) telencephalon glial cell migration(GO:0022030) |
0.4 | 2.4 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.4 | 1.2 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.4 | 2.0 | GO:0060023 | soft palate development(GO:0060023) |
0.4 | 3.5 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.4 | 0.8 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.4 | 1.2 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.4 | 1.9 | GO:0009713 | catechol-containing compound biosynthetic process(GO:0009713) catecholamine biosynthetic process(GO:0042423) |
0.4 | 1.6 | GO:0000101 | sulfur amino acid transport(GO:0000101) L-cystine transport(GO:0015811) |
0.4 | 0.4 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.4 | 0.8 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.4 | 3.1 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.4 | 0.4 | GO:0021831 | embryonic olfactory bulb interneuron precursor migration(GO:0021831) |
0.4 | 0.4 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.4 | 1.1 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.4 | 0.8 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.4 | 0.4 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.4 | 1.9 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.4 | 0.4 | GO:0070266 | necroptotic process(GO:0070266) programmed necrotic cell death(GO:0097300) |
0.4 | 4.9 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.4 | 2.3 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.4 | 0.4 | GO:0072201 | negative regulation of mesenchymal cell proliferation(GO:0072201) |
0.4 | 7.1 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.4 | 0.7 | GO:0090047 | obsolete positive regulation of transcription regulator activity(GO:0090047) |
0.4 | 2.2 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.4 | 0.7 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.4 | 0.4 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
0.4 | 4.5 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
0.4 | 1.5 | GO:0097094 | cranial suture morphogenesis(GO:0060363) craniofacial suture morphogenesis(GO:0097094) |
0.4 | 0.4 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.4 | 0.7 | GO:0060596 | mammary placode formation(GO:0060596) |
0.4 | 1.5 | GO:0042308 | negative regulation of protein import into nucleus(GO:0042308) negative regulation of nucleocytoplasmic transport(GO:0046823) negative regulation of protein localization to nucleus(GO:1900181) negative regulation of protein import(GO:1904590) |
0.4 | 0.4 | GO:0045767 | obsolete regulation of anti-apoptosis(GO:0045767) |
0.4 | 18.0 | GO:0006968 | cellular defense response(GO:0006968) |
0.4 | 1.1 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.4 | 0.4 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.4 | 1.1 | GO:0032232 | negative regulation of actin filament bundle assembly(GO:0032232) negative regulation of stress fiber assembly(GO:0051497) |
0.4 | 0.7 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
0.4 | 1.1 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.4 | 0.7 | GO:0045683 | negative regulation of epidermal cell differentiation(GO:0045605) negative regulation of keratinocyte differentiation(GO:0045617) negative regulation of epidermis development(GO:0045683) |
0.4 | 1.1 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.4 | 1.5 | GO:0019441 | tryptophan catabolic process to kynurenine(GO:0019441) |
0.4 | 1.1 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.4 | 1.5 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.4 | 0.4 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.4 | 1.1 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.4 | 1.1 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.4 | 2.2 | GO:0006546 | glycine catabolic process(GO:0006546) |
0.4 | 1.1 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
0.4 | 0.7 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.4 | 0.4 | GO:0032647 | interferon-alpha production(GO:0032607) regulation of interferon-alpha production(GO:0032647) |
0.4 | 2.5 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.4 | 5.0 | GO:0030593 | neutrophil chemotaxis(GO:0030593) neutrophil migration(GO:1990266) |
0.4 | 1.1 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.4 | 1.4 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.4 | 1.1 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.4 | 1.4 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.4 | 2.5 | GO:0006839 | mitochondrial transport(GO:0006839) |
0.4 | 5.0 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.4 | 1.4 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.4 | 0.4 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.4 | 7.5 | GO:0046847 | filopodium assembly(GO:0046847) |
0.4 | 1.4 | GO:0051788 | response to misfolded protein(GO:0051788) |
0.4 | 2.1 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.4 | 1.1 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.4 | 1.8 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.4 | 1.1 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.4 | 0.7 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.4 | 0.7 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) coumarin metabolic process(GO:0009804) |
0.4 | 1.1 | GO:0033145 | positive regulation of intracellular steroid hormone receptor signaling pathway(GO:0033145) |
0.4 | 0.7 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.4 | 0.4 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
0.4 | 0.7 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.4 | 2.1 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.4 | 0.4 | GO:0032729 | positive regulation of interferon-gamma production(GO:0032729) |
0.4 | 2.1 | GO:0006491 | N-glycan processing(GO:0006491) |
0.4 | 2.1 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.4 | 0.4 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.4 | 1.4 | GO:0031498 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.4 | 1.1 | GO:0070295 | renal water absorption(GO:0070295) |
0.4 | 3.5 | GO:0050868 | negative regulation of T cell activation(GO:0050868) negative regulation of leukocyte cell-cell adhesion(GO:1903038) |
0.3 | 0.7 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.3 | 0.7 | GO:0006007 | glucose catabolic process(GO:0006007) |
0.3 | 3.1 | GO:0001662 | behavioral fear response(GO:0001662) |
0.3 | 1.0 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.3 | 2.4 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.3 | 3.5 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.3 | 0.7 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.3 | 1.0 | GO:0045056 | transcytosis(GO:0045056) |
0.3 | 1.7 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.3 | 3.8 | GO:0050850 | positive regulation of calcium-mediated signaling(GO:0050850) |
0.3 | 0.3 | GO:0001705 | ectoderm formation(GO:0001705) |
0.3 | 1.4 | GO:0002097 | tRNA wobble base modification(GO:0002097) tRNA wobble uridine modification(GO:0002098) tRNA thio-modification(GO:0034227) |
0.3 | 0.3 | GO:1901863 | positive regulation of striated muscle tissue development(GO:0045844) positive regulation of muscle organ development(GO:0048636) positive regulation of muscle tissue development(GO:1901863) |
0.3 | 0.7 | GO:0046323 | glucose import(GO:0046323) |
0.3 | 0.7 | GO:0034969 | histone arginine methylation(GO:0034969) |
0.3 | 1.4 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.3 | 0.3 | GO:0043931 | ossification involved in bone maturation(GO:0043931) |
0.3 | 1.4 | GO:0009109 | coenzyme catabolic process(GO:0009109) |
0.3 | 1.0 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.3 | 0.7 | GO:0060049 | regulation of protein glycosylation(GO:0060049) |
0.3 | 1.7 | GO:0006929 | substrate-dependent cell migration(GO:0006929) |
0.3 | 1.7 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.3 | 0.3 | GO:0050672 | negative regulation of mononuclear cell proliferation(GO:0032945) negative regulation of lymphocyte proliferation(GO:0050672) |
0.3 | 1.0 | GO:0046398 | UDP-glucuronate metabolic process(GO:0046398) |
0.3 | 0.7 | GO:0071501 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.3 | 1.7 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.3 | 0.3 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.3 | 0.3 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.3 | 1.0 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.3 | 0.7 | GO:0051451 | myoblast migration(GO:0051451) |
0.3 | 0.3 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
0.3 | 4.6 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.3 | 1.3 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.3 | 0.3 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.3 | 3.0 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.3 | 3.0 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
0.3 | 0.7 | GO:0070857 | regulation of bile acid biosynthetic process(GO:0070857) regulation of bile acid metabolic process(GO:1904251) |
0.3 | 1.6 | GO:0009304 | tRNA transcription(GO:0009304) |
0.3 | 2.0 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.3 | 2.6 | GO:1903322 | positive regulation of protein modification by small protein conjugation or removal(GO:1903322) |
0.3 | 1.0 | GO:0009215 | purine deoxyribonucleoside triphosphate metabolic process(GO:0009215) |
0.3 | 0.6 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.3 | 0.6 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.3 | 1.9 | GO:0045730 | respiratory burst(GO:0045730) |
0.3 | 0.6 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.3 | 1.0 | GO:0050665 | hydrogen peroxide biosynthetic process(GO:0050665) |
0.3 | 1.0 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
0.3 | 1.6 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.3 | 1.3 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.3 | 1.0 | GO:0043276 | anoikis(GO:0043276) |
0.3 | 2.5 | GO:0015884 | folic acid transport(GO:0015884) |
0.3 | 0.6 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.3 | 1.9 | GO:0051322 | anaphase(GO:0051322) |
0.3 | 0.9 | GO:0007207 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.3 | 0.9 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.3 | 0.9 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.3 | 0.3 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.3 | 1.6 | GO:0030163 | protein catabolic process(GO:0030163) |
0.3 | 0.6 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.3 | 0.3 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.3 | 0.9 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.3 | 0.6 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.3 | 0.3 | GO:0010517 | regulation of phospholipase activity(GO:0010517) |
0.3 | 0.6 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.3 | 1.9 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.3 | 1.9 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.3 | 0.3 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.3 | 0.3 | GO:0001302 | replicative cell aging(GO:0001302) |
0.3 | 0.3 | GO:0045165 | cell fate commitment(GO:0045165) |
0.3 | 1.8 | GO:0045749 | obsolete negative regulation of S phase of mitotic cell cycle(GO:0045749) |
0.3 | 0.9 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) positive regulation of cell cycle checkpoint(GO:1901978) regulation of mitotic spindle checkpoint(GO:1903504) |
0.3 | 1.5 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.3 | 1.2 | GO:0046606 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.3 | 0.3 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.3 | 1.2 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.3 | 1.5 | GO:0001570 | vasculogenesis(GO:0001570) |
0.3 | 12.4 | GO:0034138 | toll-like receptor 3 signaling pathway(GO:0034138) |
0.3 | 0.6 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.3 | 0.6 | GO:0030330 | DNA damage response, signal transduction by p53 class mediator(GO:0030330) |
0.3 | 1.5 | GO:0006983 | ER overload response(GO:0006983) |
0.3 | 5.4 | GO:0000080 | mitotic G1 phase(GO:0000080) |
0.3 | 0.6 | GO:0071436 | sodium ion export(GO:0071436) |
0.3 | 0.6 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) negative regulation of anion transmembrane transport(GO:1903960) negative regulation of fatty acid transport(GO:2000192) |
0.3 | 1.5 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.3 | 0.3 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.3 | 7.1 | GO:0050680 | negative regulation of epithelial cell proliferation(GO:0050680) |
0.3 | 3.3 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.3 | 1.2 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.3 | 1.2 | GO:0045916 | negative regulation of humoral immune response(GO:0002921) negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.3 | 0.9 | GO:0071428 | rRNA-containing ribonucleoprotein complex export from nucleus(GO:0071428) |
0.3 | 8.8 | GO:0010977 | negative regulation of neuron projection development(GO:0010977) |
0.3 | 2.1 | GO:0072506 | phosphate ion homeostasis(GO:0055062) divalent inorganic anion homeostasis(GO:0072505) trivalent inorganic anion homeostasis(GO:0072506) |
0.3 | 0.9 | GO:0007140 | male meiosis(GO:0007140) |
0.3 | 1.5 | GO:0015780 | nucleotide-sugar transport(GO:0015780) |
0.3 | 0.9 | GO:0030516 | regulation of axon extension(GO:0030516) |
0.3 | 0.3 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.3 | 0.9 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.3 | 1.4 | GO:0036230 | granulocyte activation(GO:0036230) |
0.3 | 0.6 | GO:0039656 | modulation by virus of host gene expression(GO:0039656) |
0.3 | 4.0 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.3 | 0.3 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.3 | 0.3 | GO:0002724 | regulation of T cell cytokine production(GO:0002724) |
0.3 | 0.9 | GO:0044091 | membrane biogenesis(GO:0044091) |
0.3 | 2.3 | GO:1903846 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.3 | 0.3 | GO:0001821 | histamine secretion(GO:0001821) |
0.3 | 0.6 | GO:0021681 | cerebellar granular layer development(GO:0021681) cerebellar granular layer morphogenesis(GO:0021683) cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.3 | 2.8 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.3 | 0.9 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.3 | 0.6 | GO:0019042 | viral latency(GO:0019042) |
0.3 | 0.9 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.3 | 11.9 | GO:0007498 | mesoderm development(GO:0007498) |
0.3 | 0.3 | GO:0050879 | multicellular organismal movement(GO:0050879) musculoskeletal movement(GO:0050881) |
0.3 | 2.8 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.3 | 2.3 | GO:0007007 | inner mitochondrial membrane organization(GO:0007007) |
0.3 | 2.3 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
0.3 | 0.6 | GO:0022602 | ovulation cycle process(GO:0022602) |
0.3 | 0.6 | GO:0007143 | female meiotic division(GO:0007143) |
0.3 | 0.3 | GO:0010389 | regulation of G2/M transition of mitotic cell cycle(GO:0010389) regulation of cell cycle G2/M phase transition(GO:1902749) |
0.3 | 0.8 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.3 | 1.1 | GO:0042506 | tyrosine phosphorylation of Stat5 protein(GO:0042506) |
0.3 | 1.4 | GO:0071445 | obsolete cellular response to protein stimulus(GO:0071445) |
0.3 | 0.6 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.3 | 1.1 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.3 | 0.3 | GO:0001556 | oocyte maturation(GO:0001556) |
0.3 | 0.3 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.3 | 0.3 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
0.3 | 0.8 | GO:0034311 | sphingosine metabolic process(GO:0006670) diol metabolic process(GO:0034311) |
0.3 | 0.5 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.3 | 1.9 | GO:0009650 | UV protection(GO:0009650) |
0.3 | 0.3 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
0.3 | 0.5 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.3 | 0.5 | GO:0003211 | cardiac chamber formation(GO:0003207) cardiac ventricle formation(GO:0003211) |
0.3 | 1.4 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.3 | 5.5 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.3 | 0.5 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.3 | 0.5 | GO:0030240 | skeletal myofibril assembly(GO:0014866) skeletal muscle thin filament assembly(GO:0030240) |
0.3 | 2.2 | GO:0032456 | endocytic recycling(GO:0032456) |
0.3 | 6.2 | GO:1901799 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) negative regulation of proteasomal protein catabolic process(GO:1901799) |
0.3 | 3.0 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.3 | 2.7 | GO:0010039 | response to iron ion(GO:0010039) |
0.3 | 1.9 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.3 | 0.5 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.3 | 1.1 | GO:0002920 | regulation of humoral immune response(GO:0002920) |
0.3 | 2.1 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.3 | 0.3 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.3 | 0.3 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.3 | 4.5 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.3 | 0.5 | GO:0045684 | positive regulation of epidermis development(GO:0045684) |
0.3 | 0.3 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.3 | 0.3 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.3 | 1.3 | GO:0006906 | vesicle fusion(GO:0006906) |
0.3 | 2.9 | GO:0008380 | RNA splicing(GO:0008380) |
0.3 | 1.3 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.3 | 1.8 | GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) extrinsic apoptotic signaling pathway(GO:0097191) |
0.3 | 2.4 | GO:0006069 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.3 | 0.3 | GO:0051882 | mitochondrial depolarization(GO:0051882) |
0.3 | 0.5 | GO:0032715 | negative regulation of interleukin-6 production(GO:0032715) |
0.3 | 0.3 | GO:0035821 | modification of morphology or physiology of other organism(GO:0035821) |
0.3 | 0.3 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.3 | 1.8 | GO:0006465 | signal peptide processing(GO:0006465) |
0.3 | 0.5 | GO:0018119 | protein nitrosylation(GO:0017014) peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.3 | 1.6 | GO:0030238 | male sex determination(GO:0030238) |
0.3 | 1.6 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.3 | 3.1 | GO:0007032 | endosome organization(GO:0007032) |
0.3 | 1.0 | GO:0000012 | single strand break repair(GO:0000012) |
0.3 | 0.5 | GO:0001881 | receptor recycling(GO:0001881) |
0.3 | 4.1 | GO:0006305 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
0.3 | 8.7 | GO:0030816 | positive regulation of cAMP metabolic process(GO:0030816) positive regulation of cAMP biosynthetic process(GO:0030819) |
0.3 | 0.8 | GO:0001945 | lymph vessel development(GO:0001945) |
0.3 | 0.8 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.3 | 2.5 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.3 | 0.3 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.3 | 0.3 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.3 | 0.8 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.3 | 0.5 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.3 | 2.8 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.3 | 0.3 | GO:0016577 | histone demethylation(GO:0016577) |
0.3 | 0.5 | GO:0072047 | proximal/distal pattern formation involved in nephron development(GO:0072047) specification of nephron tubule identity(GO:0072081) |
0.3 | 0.3 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.3 | 0.3 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.3 | 1.0 | GO:0008218 | bioluminescence(GO:0008218) |
0.3 | 0.5 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.2 | 1.2 | GO:0060761 | negative regulation of response to cytokine stimulus(GO:0060761) |
0.2 | 1.0 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.2 | 1.0 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.2 | 0.7 | GO:0050798 | activated T cell proliferation(GO:0050798) |
0.2 | 0.5 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.2 | 4.4 | GO:0043487 | regulation of RNA stability(GO:0043487) |
0.2 | 0.2 | GO:0033151 | V(D)J recombination(GO:0033151) |
0.2 | 0.2 | GO:0072194 | kidney smooth muscle tissue development(GO:0072194) |
0.2 | 0.7 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.2 | 0.5 | GO:0043949 | regulation of cAMP-mediated signaling(GO:0043949) |
0.2 | 5.6 | GO:1901185 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
0.2 | 0.2 | GO:0006534 | cysteine metabolic process(GO:0006534) |
0.2 | 0.5 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.2 | 1.0 | GO:0019915 | lipid storage(GO:0019915) |
0.2 | 1.2 | GO:0045116 | protein neddylation(GO:0045116) |
0.2 | 2.6 | GO:1905037 | autophagosome assembly(GO:0000045) autophagosome organization(GO:1905037) |
0.2 | 0.2 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.2 | 0.7 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.2 | 1.0 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.2 | 1.0 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.2 | 1.4 | GO:0097384 | cellular lipid biosynthetic process(GO:0097384) |
0.2 | 5.7 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.2 | 0.2 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.2 | 2.6 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.2 | 0.7 | GO:0031507 | heterochromatin assembly(GO:0031507) heterochromatin organization(GO:0070828) |
0.2 | 0.2 | GO:0048675 | axon extension(GO:0048675) neuron projection extension(GO:1990138) |
0.2 | 0.9 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.2 | 0.5 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.2 | 2.8 | GO:0016925 | protein sumoylation(GO:0016925) |
0.2 | 0.2 | GO:0051101 | regulation of DNA binding(GO:0051101) |
0.2 | 2.1 | GO:0019059 | obsolete initiation of viral infection(GO:0019059) |
0.2 | 0.7 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.2 | 0.2 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.2 | 1.2 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.2 | 0.5 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.2 | 0.2 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.2 | 0.9 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
0.2 | 0.2 | GO:0002532 | production of molecular mediator involved in inflammatory response(GO:0002532) |
0.2 | 0.2 | GO:0000216 | obsolete M/G1 transition of mitotic cell cycle(GO:0000216) |
0.2 | 0.9 | GO:0008584 | male gonad development(GO:0008584) development of primary male sexual characteristics(GO:0046546) |
0.2 | 0.2 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.2 | 0.7 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
0.2 | 0.7 | GO:0045005 | DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
0.2 | 0.5 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.2 | 0.5 | GO:0006595 | polyamine metabolic process(GO:0006595) |
0.2 | 2.7 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.2 | 1.6 | GO:0007416 | synapse assembly(GO:0007416) |
0.2 | 1.3 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.2 | 0.9 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) positive regulation of protein localization to plasma membrane(GO:1903078) positive regulation of protein localization to cell periphery(GO:1904377) |
0.2 | 0.9 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.2 | 0.2 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.2 | 0.2 | GO:0006273 | lagging strand elongation(GO:0006273) |
0.2 | 0.4 | GO:0010561 | negative regulation of glycoprotein biosynthetic process(GO:0010561) |
0.2 | 0.2 | GO:0046660 | female sex differentiation(GO:0046660) |
0.2 | 0.2 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.2 | 0.4 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.2 | 0.2 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
0.2 | 1.5 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.2 | 1.5 | GO:0007141 | male meiosis I(GO:0007141) |
0.2 | 0.4 | GO:1902117 | positive regulation of organelle assembly(GO:1902117) |
0.2 | 0.4 | GO:0045410 | response to bacterial lipoprotein(GO:0032493) detection of bacterial lipoprotein(GO:0042494) positive regulation of interleukin-6 biosynthetic process(GO:0045410) response to bacterial lipopeptide(GO:0070339) detection of bacterial lipopeptide(GO:0070340) cellular response to bacterial lipoprotein(GO:0071220) cellular response to bacterial lipopeptide(GO:0071221) |
0.2 | 0.2 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.2 | 0.9 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.2 | 0.2 | GO:0043368 | positive T cell selection(GO:0043368) |
0.2 | 0.9 | GO:0019062 | virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) |
0.2 | 1.7 | GO:0006621 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.2 | 0.4 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.2 | 0.4 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.2 | 1.1 | GO:0033692 | cellular polysaccharide biosynthetic process(GO:0033692) |
0.2 | 0.4 | GO:0072600 | protein targeting to Golgi(GO:0000042) establishment of protein localization to Golgi(GO:0072600) |
0.2 | 1.1 | GO:0098534 | centriole replication(GO:0007099) centriole assembly(GO:0098534) |
0.2 | 0.6 | GO:0006565 | L-serine catabolic process(GO:0006565) |
0.2 | 0.4 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.2 | 1.3 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.2 | 2.1 | GO:1901661 | quinone metabolic process(GO:1901661) |
0.2 | 0.8 | GO:0007091 | metaphase/anaphase transition of mitotic cell cycle(GO:0007091) regulation of mitotic sister chromatid separation(GO:0010965) regulation of mitotic sister chromatid segregation(GO:0033047) metaphase/anaphase transition of cell cycle(GO:0044784) mitotic sister chromatid separation(GO:0051306) |
0.2 | 12.3 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
0.2 | 0.2 | GO:0070265 | necrotic cell death(GO:0070265) |
0.2 | 0.4 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.2 | 0.6 | GO:0006477 | protein sulfation(GO:0006477) |
0.2 | 3.1 | GO:0071554 | cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.2 | 0.8 | GO:0072666 | protein targeting to lysosome(GO:0006622) protein targeting to vacuole(GO:0006623) protein localization to lysosome(GO:0061462) protein localization to vacuole(GO:0072665) establishment of protein localization to vacuole(GO:0072666) |
0.2 | 0.6 | GO:0051567 | histone H3-K9 methylation(GO:0051567) histone H3-K9 modification(GO:0061647) |
0.2 | 1.2 | GO:0010259 | multicellular organism aging(GO:0010259) |
0.2 | 0.4 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.2 | 6.6 | GO:0005977 | glycogen metabolic process(GO:0005977) |
0.2 | 0.8 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.2 | 0.6 | GO:0051294 | establishment of mitotic spindle orientation(GO:0000132) establishment of spindle orientation(GO:0051294) |
0.2 | 5.9 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.2 | 1.0 | GO:0030500 | regulation of bone mineralization(GO:0030500) |
0.2 | 1.0 | GO:0042246 | tissue regeneration(GO:0042246) |
0.2 | 0.6 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.2 | 0.8 | GO:0031272 | pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
0.2 | 0.6 | GO:0014904 | myotube cell development(GO:0014904) skeletal muscle fiber development(GO:0048741) |
0.2 | 0.6 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.2 | 1.4 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.2 | 2.0 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.2 | 0.4 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.2 | 1.0 | GO:0002483 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.2 | 1.0 | GO:0070193 | synaptonemal complex organization(GO:0070193) |
0.2 | 0.8 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.2 | 0.4 | GO:0060192 | negative regulation of lipoprotein lipase activity(GO:0051005) negative regulation of lipase activity(GO:0060192) |
0.2 | 0.6 | GO:0006573 | valine metabolic process(GO:0006573) |
0.2 | 0.6 | GO:0046618 | drug export(GO:0046618) |
0.2 | 0.4 | GO:0032106 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) positive regulation of response to extracellular stimulus(GO:0032106) positive regulation of response to nutrient levels(GO:0032109) |
0.2 | 7.0 | GO:0010827 | regulation of glucose transport(GO:0010827) |
0.2 | 0.6 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.2 | 0.2 | GO:0010771 | negative regulation of cell morphogenesis involved in differentiation(GO:0010771) |
0.2 | 1.8 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.2 | 0.4 | GO:0034367 | macromolecular complex remodeling(GO:0034367) protein-lipid complex remodeling(GO:0034368) plasma lipoprotein particle remodeling(GO:0034369) |
0.2 | 2.5 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.2 | 1.0 | GO:0016556 | mRNA modification(GO:0016556) |
0.2 | 0.2 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.2 | 0.4 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.2 | 1.2 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.2 | 2.3 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.2 | 3.8 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.2 | 0.2 | GO:0008634 | obsolete negative regulation of survival gene product expression(GO:0008634) |
0.2 | 0.4 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.2 | 0.4 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.2 | 0.4 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.2 | 1.1 | GO:0031647 | regulation of protein stability(GO:0031647) |
0.2 | 0.4 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.2 | 1.0 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.2 | 1.0 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.2 | 0.6 | GO:0034339 | obsolete regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor(GO:0034339) |
0.2 | 0.6 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.2 | 0.7 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.2 | 0.2 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.2 | 0.9 | GO:1903321 | negative regulation of protein modification by small protein conjugation or removal(GO:1903321) |
0.2 | 0.2 | GO:0061339 | establishment of apical/basal cell polarity(GO:0035089) establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
0.2 | 0.6 | GO:0009414 | response to water deprivation(GO:0009414) response to water(GO:0009415) |
0.2 | 0.6 | GO:0034394 | protein localization to cell surface(GO:0034394) |
0.2 | 1.5 | GO:0006401 | RNA catabolic process(GO:0006401) |
0.2 | 1.5 | GO:0001947 | heart looping(GO:0001947) embryonic heart tube morphogenesis(GO:0003143) determination of heart left/right asymmetry(GO:0061371) |
0.2 | 6.3 | GO:0051084 | 'de novo' posttranslational protein folding(GO:0051084) |
0.2 | 0.9 | GO:0019221 | cytokine-mediated signaling pathway(GO:0019221) |
0.2 | 0.4 | GO:0060323 | head morphogenesis(GO:0060323) |
0.2 | 1.3 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.2 | 0.2 | GO:0031223 | auditory behavior(GO:0031223) |
0.2 | 0.2 | GO:0061037 | negative regulation of chondrocyte differentiation(GO:0032331) negative regulation of cartilage development(GO:0061037) |
0.2 | 0.2 | GO:0006111 | regulation of gluconeogenesis(GO:0006111) |
0.2 | 0.2 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.2 | 1.3 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.2 | 0.5 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.2 | 0.5 | GO:0021799 | cerebral cortex radially oriented cell migration(GO:0021799) |
0.2 | 0.2 | GO:0021898 | cerebral cortex GABAergic interneuron differentiation(GO:0021892) commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.2 | 4.3 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.2 | 0.2 | GO:0008593 | regulation of Notch signaling pathway(GO:0008593) |
0.2 | 4.0 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.2 | 0.9 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.2 | 0.4 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
0.2 | 1.6 | GO:0048207 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) COPII-coated vesicle budding(GO:0090114) |
0.2 | 0.5 | GO:0051926 | negative regulation of calcium ion transport(GO:0051926) |
0.2 | 0.2 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.2 | 0.2 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.2 | 0.2 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.2 | 1.8 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.2 | 0.7 | GO:0018200 | peptidyl-glutamic acid modification(GO:0018200) |
0.2 | 0.4 | GO:0031668 | cellular response to extracellular stimulus(GO:0031668) |
0.2 | 0.4 | GO:0021794 | thalamus development(GO:0021794) |
0.2 | 0.5 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.2 | 0.3 | GO:0050818 | regulation of coagulation(GO:0050818) |
0.2 | 0.5 | GO:0071569 | protein ufmylation(GO:0071569) |
0.2 | 0.2 | GO:1902115 | regulation of organelle assembly(GO:1902115) |
0.2 | 0.7 | GO:0006378 | mRNA polyadenylation(GO:0006378) |
0.2 | 1.7 | GO:0042551 | neuron maturation(GO:0042551) |
0.2 | 0.9 | GO:0010165 | response to X-ray(GO:0010165) |
0.2 | 0.2 | GO:0072148 | epithelial cell fate commitment(GO:0072148) |
0.2 | 1.0 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
0.2 | 0.3 | GO:0031958 | corticosteroid receptor signaling pathway(GO:0031958) glucocorticoid receptor signaling pathway(GO:0042921) |
0.2 | 1.4 | GO:0048536 | spleen development(GO:0048536) |
0.2 | 0.2 | GO:2000758 | positive regulation of histone acetylation(GO:0035066) positive regulation of protein acetylation(GO:1901985) positive regulation of peptidyl-lysine acetylation(GO:2000758) |
0.2 | 1.9 | GO:0009988 | cell-cell recognition(GO:0009988) |
0.2 | 9.1 | GO:0018279 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.2 | 0.2 | GO:0060456 | regulation of saliva secretion(GO:0046877) positive regulation of digestive system process(GO:0060456) |
0.2 | 0.2 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.2 | 0.2 | GO:0006984 | ER-nucleus signaling pathway(GO:0006984) |
0.2 | 2.9 | GO:0048017 | phosphatidylinositol-mediated signaling(GO:0048015) inositol lipid-mediated signaling(GO:0048017) |
0.2 | 0.8 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.2 | 2.2 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.2 | 0.3 | GO:0008049 | male courtship behavior(GO:0008049) |
0.2 | 0.5 | GO:0001508 | action potential(GO:0001508) |
0.2 | 1.2 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.2 | 2.8 | GO:0019079 | viral genome replication(GO:0019079) |
0.2 | 0.3 | GO:0006298 | mismatch repair(GO:0006298) |
0.2 | 0.5 | GO:0050773 | regulation of dendrite development(GO:0050773) |
0.2 | 0.5 | GO:0043631 | RNA polyadenylation(GO:0043631) |
0.2 | 2.6 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.2 | 0.3 | GO:0048535 | lymph node development(GO:0048535) |
0.2 | 0.2 | GO:0060914 | heart formation(GO:0060914) |
0.2 | 0.6 | GO:0071265 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.2 | 0.3 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.2 | 1.1 | GO:0051789 | obsolete response to protein(GO:0051789) |
0.2 | 2.1 | GO:0042384 | cilium assembly(GO:0042384) |
0.2 | 0.3 | GO:0032418 | lysosome localization(GO:0032418) |
0.2 | 7.3 | GO:0071357 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
0.2 | 3.3 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.2 | 1.6 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.2 | 5.9 | GO:0006898 | receptor-mediated endocytosis(GO:0006898) |
0.2 | 0.3 | GO:0016199 | axon choice point recognition(GO:0016198) axon midline choice point recognition(GO:0016199) |
0.2 | 0.8 | GO:0051452 | intracellular pH reduction(GO:0051452) |
0.2 | 0.5 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.2 | 0.3 | GO:0010821 | regulation of mitochondrion organization(GO:0010821) |
0.2 | 0.5 | GO:0034370 | triglyceride-rich lipoprotein particle remodeling(GO:0034370) very-low-density lipoprotein particle remodeling(GO:0034372) |
0.2 | 5.5 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.2 | 2.2 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.2 | 0.3 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
0.2 | 0.2 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.2 | 1.1 | GO:0051324 | prophase(GO:0051324) |
0.2 | 0.2 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.2 | 0.2 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.2 | 0.3 | GO:0060317 | cardiac epithelial to mesenchymal transition(GO:0060317) |
0.2 | 1.7 | GO:0034612 | response to tumor necrosis factor(GO:0034612) |
0.2 | 0.8 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.2 | 0.3 | GO:0035094 | response to nicotine(GO:0035094) |
0.2 | 0.3 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.2 | 1.4 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.2 | 4.2 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.2 | 1.5 | GO:0051607 | defense response to virus(GO:0051607) |
0.1 | 0.4 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.1 | 0.3 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
0.1 | 0.4 | GO:0042756 | drinking behavior(GO:0042756) |
0.1 | 0.3 | GO:0036473 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) cell death in response to oxidative stress(GO:0036473) |
0.1 | 0.4 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.1 | 0.3 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.1 | 2.1 | GO:0006400 | tRNA modification(GO:0006400) |
0.1 | 0.3 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
0.1 | 0.7 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.1 | 0.3 | GO:0032366 | intracellular sterol transport(GO:0032366) intracellular cholesterol transport(GO:0032367) |
0.1 | 1.0 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.1 | 0.4 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.1 | 0.1 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.1 | 0.1 | GO:0031123 | RNA 3'-end processing(GO:0031123) |
0.1 | 0.3 | GO:1903301 | regulation of glucokinase activity(GO:0033131) positive regulation of glucokinase activity(GO:0033133) regulation of hexokinase activity(GO:1903299) positive regulation of hexokinase activity(GO:1903301) |
0.1 | 2.0 | GO:0051329 | mitotic interphase(GO:0051329) |
0.1 | 0.6 | GO:0006264 | mitochondrial DNA replication(GO:0006264) mitochondrial DNA metabolic process(GO:0032042) |
0.1 | 0.7 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.1 | 0.6 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.1 | 1.4 | GO:0001709 | cell fate determination(GO:0001709) |
0.1 | 0.4 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.1 | 0.7 | GO:0016446 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.1 | 0.3 | GO:0002544 | chronic inflammatory response(GO:0002544) |
0.1 | 0.3 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.1 | 3.7 | GO:0007286 | spermatid development(GO:0007286) |
0.1 | 0.6 | GO:0032411 | positive regulation of transporter activity(GO:0032411) |
0.1 | 0.6 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.1 | 0.4 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.1 | 1.6 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.1 | 1.1 | GO:0050832 | defense response to fungus(GO:0050832) |
0.1 | 0.6 | GO:0007549 | dosage compensation(GO:0007549) |
0.1 | 1.4 | GO:0035601 | protein deacylation(GO:0035601) macromolecule deacylation(GO:0098732) |
0.1 | 0.4 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.1 | 0.1 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.1 | 0.4 | GO:0032202 | telomere assembly(GO:0032202) |
0.1 | 0.7 | GO:0046036 | GTP biosynthetic process(GO:0006183) UTP biosynthetic process(GO:0006228) CTP biosynthetic process(GO:0006241) pyrimidine nucleoside triphosphate biosynthetic process(GO:0009148) pyrimidine ribonucleoside triphosphate metabolic process(GO:0009208) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) CTP metabolic process(GO:0046036) UTP metabolic process(GO:0046051) |
0.1 | 2.1 | GO:0000724 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.1 | 1.5 | GO:0034968 | histone lysine methylation(GO:0034968) |
0.1 | 28.6 | GO:0006397 | mRNA processing(GO:0006397) |
0.1 | 0.1 | GO:0002366 | cell activation involved in immune response(GO:0002263) leukocyte activation involved in immune response(GO:0002366) |
0.1 | 2.7 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.1 | 0.1 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.1 | 13.9 | GO:0006470 | protein dephosphorylation(GO:0006470) |
0.1 | 1.9 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.1 | 0.1 | GO:0071636 | transforming growth factor beta1 production(GO:0032905) regulation of transforming growth factor beta1 production(GO:0032908) positive regulation of transforming growth factor beta production(GO:0071636) |
0.1 | 0.1 | GO:0045780 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.1 | 0.4 | GO:0007530 | sex determination(GO:0007530) |
0.1 | 0.1 | GO:0032782 | canalicular bile acid transport(GO:0015722) bile acid secretion(GO:0032782) |
0.1 | 0.4 | GO:0021675 | nerve development(GO:0021675) |
0.1 | 0.3 | GO:0021697 | cerebellar cortex formation(GO:0021697) |
0.1 | 0.1 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.1 | 0.1 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.1 | 0.4 | GO:0001832 | blastocyst growth(GO:0001832) |
0.1 | 0.4 | GO:0034130 | toll-like receptor 1 signaling pathway(GO:0034130) toll-like receptor 2 signaling pathway(GO:0034134) |
0.1 | 1.2 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 0.1 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.1 | 0.1 | GO:0006458 | 'de novo' protein folding(GO:0006458) |
0.1 | 1.3 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
0.1 | 0.3 | GO:0018216 | peptidyl-arginine methylation(GO:0018216) |
0.1 | 1.2 | GO:0009309 | amine biosynthetic process(GO:0009309) |
0.1 | 1.0 | GO:0010458 | exit from mitosis(GO:0010458) |
0.1 | 1.2 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.1 | 0.8 | GO:0009303 | rRNA transcription(GO:0009303) |
0.1 | 0.7 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.1 | 0.6 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.1 | 0.1 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.1 | 0.1 | GO:0016445 | somatic diversification of immunoglobulins(GO:0016445) |
0.1 | 4.6 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
0.1 | 0.3 | GO:0050691 | regulation of defense response to virus by host(GO:0050691) |
0.1 | 0.9 | GO:0048011 | neurotrophin signaling pathway(GO:0038179) neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.1 | 0.8 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.1 | 0.8 | GO:0045667 | regulation of osteoblast differentiation(GO:0045667) |
0.1 | 0.8 | GO:0000718 | nucleotide-excision repair, DNA damage removal(GO:0000718) DNA excision(GO:0044349) |
0.1 | 0.1 | GO:0007260 | tyrosine phosphorylation of STAT protein(GO:0007260) |
0.1 | 1.5 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.1 | 0.6 | GO:0008595 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.1 | 5.9 | GO:0008033 | tRNA processing(GO:0008033) |
0.1 | 1.0 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.1 | 2.0 | GO:0031047 | gene silencing by RNA(GO:0031047) |
0.1 | 0.4 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.1 | 0.3 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 4.9 | GO:0000087 | mitotic M phase(GO:0000087) |
0.1 | 0.3 | GO:0043441 | acetoacetic acid biosynthetic process(GO:0043441) |
0.1 | 9.7 | GO:0000082 | G1/S transition of mitotic cell cycle(GO:0000082) cell cycle G1/S phase transition(GO:0044843) |
0.1 | 0.2 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.1 | 0.4 | GO:0009070 | serine family amino acid biosynthetic process(GO:0009070) |
0.1 | 0.6 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
0.1 | 1.6 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.1 | 0.5 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.1 | 0.6 | GO:0070588 | calcium ion transmembrane transport(GO:0070588) |
0.1 | 0.1 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.1 | 1.2 | GO:0035966 | response to unfolded protein(GO:0006986) response to topologically incorrect protein(GO:0035966) |
0.1 | 0.4 | GO:0001757 | somite specification(GO:0001757) |
0.1 | 0.1 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.1 | 1.0 | GO:0045930 | negative regulation of mitotic cell cycle(GO:0045930) |
0.1 | 0.4 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.1 | 0.2 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.1 | 0.2 | GO:1903115 | regulation of muscle filament sliding(GO:0032971) regulation of actin filament-based movement(GO:1903115) |
0.1 | 0.9 | GO:0002088 | lens development in camera-type eye(GO:0002088) |
0.1 | 0.2 | GO:0051298 | centrosome duplication(GO:0051298) |
0.1 | 0.1 | GO:0043954 | cellular component maintenance(GO:0043954) |
0.1 | 0.6 | GO:0044275 | cellular carbohydrate catabolic process(GO:0044275) |
0.1 | 0.5 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.1 | 0.5 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
0.1 | 0.6 | GO:0046320 | regulation of fatty acid oxidation(GO:0046320) |
0.1 | 1.5 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.1 | 0.1 | GO:0016571 | histone methylation(GO:0016571) |
0.1 | 0.7 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.1 | 0.1 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.1 | 0.1 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.1 | 0.2 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.1 | 0.2 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.1 | 0.9 | GO:0007219 | Notch signaling pathway(GO:0007219) |
0.1 | 1.2 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 0.2 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.1 | 0.6 | GO:1901998 | tetracycline transport(GO:0015904) antibiotic transport(GO:0042891) toxin transport(GO:1901998) |
0.1 | 0.1 | GO:2000106 | regulation of leukocyte apoptotic process(GO:2000106) |
0.1 | 4.3 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.1 | 0.8 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.1 | 5.0 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.1 | 0.4 | GO:0006862 | nucleotide transport(GO:0006862) |
0.1 | 1.0 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.1 | GO:0001702 | gastrulation with mouth forming second(GO:0001702) |
0.1 | 1.2 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.1 | 0.2 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.1 | 0.4 | GO:0034214 | protein hexamerization(GO:0034214) |
0.1 | 0.4 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.1 | 3.9 | GO:0007034 | vacuolar transport(GO:0007034) |
0.1 | 0.3 | GO:0032368 | regulation of lipid transport(GO:0032368) |
0.1 | 0.1 | GO:0006560 | proline metabolic process(GO:0006560) proline catabolic process(GO:0006562) |
0.1 | 0.3 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 2.8 | GO:0007265 | Ras protein signal transduction(GO:0007265) |
0.1 | 8.9 | GO:0016032 | viral process(GO:0016032) |
0.1 | 1.1 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.1 | 0.2 | GO:0021854 | hypothalamus development(GO:0021854) |
0.1 | 2.9 | GO:0019932 | second-messenger-mediated signaling(GO:0019932) |
0.1 | 0.3 | GO:0021766 | hippocampus development(GO:0021766) |
0.1 | 0.1 | GO:0045423 | regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.1 | 1.4 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
0.1 | 0.5 | GO:0006553 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
0.1 | 0.2 | GO:1903037 | regulation of T cell activation(GO:0050863) regulation of leukocyte cell-cell adhesion(GO:1903037) |
0.1 | 0.3 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.1 | 0.3 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.1 | 0.3 | GO:0035581 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.1 | 0.6 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.1 | 1.3 | GO:0009311 | oligosaccharide metabolic process(GO:0009311) |
0.1 | 0.2 | GO:0001696 | gastric acid secretion(GO:0001696) |
0.1 | 0.2 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.1 | 0.1 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
0.1 | 0.2 | GO:0043030 | regulation of macrophage activation(GO:0043030) |
0.1 | 0.1 | GO:0051354 | negative regulation of oxidoreductase activity(GO:0051354) |
0.1 | 2.1 | GO:0022900 | electron transport chain(GO:0022900) |
0.1 | 0.2 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.1 | 1.8 | GO:0031023 | microtubule organizing center organization(GO:0031023) |
0.1 | 0.2 | GO:0043501 | skeletal muscle adaptation(GO:0043501) |
0.1 | 3.6 | GO:0006486 | protein glycosylation(GO:0006486) macromolecule glycosylation(GO:0043413) glycosylation(GO:0070085) |
0.1 | 0.1 | GO:0060349 | bone morphogenesis(GO:0060349) |
0.1 | 0.5 | GO:0006026 | aminoglycan catabolic process(GO:0006026) |
0.1 | 0.1 | GO:0048263 | determination of dorsal identity(GO:0048263) |
0.1 | 0.1 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.1 | 0.6 | GO:0042044 | water transport(GO:0006833) fluid transport(GO:0042044) |
0.1 | 0.4 | GO:0042475 | odontogenesis of dentin-containing tooth(GO:0042475) |
0.1 | 0.2 | GO:0016559 | peroxisome fission(GO:0016559) |
0.1 | 0.1 | GO:0015802 | basic amino acid transport(GO:0015802) |
0.1 | 0.1 | GO:0042026 | protein refolding(GO:0042026) |
0.1 | 0.2 | GO:0007567 | parturition(GO:0007567) |
0.1 | 0.4 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.1 | 0.5 | GO:0032635 | interleukin-6 production(GO:0032635) |
0.1 | 0.1 | GO:0051608 | histamine transport(GO:0051608) |
0.1 | 2.0 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.1 | 0.2 | GO:0042269 | regulation of natural killer cell mediated immunity(GO:0002715) regulation of natural killer cell mediated cytotoxicity(GO:0042269) |
0.1 | 0.3 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.1 | 1.4 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.1 | 0.8 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.1 | 0.2 | GO:0007512 | adult heart development(GO:0007512) |
0.1 | 0.2 | GO:0006261 | DNA-dependent DNA replication(GO:0006261) |
0.1 | 7.6 | GO:0043087 | regulation of GTPase activity(GO:0043087) |
0.1 | 15.6 | GO:0006955 | immune response(GO:0006955) |
0.1 | 3.8 | GO:0006959 | humoral immune response(GO:0006959) |
0.1 | 2.4 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.1 | 5.4 | GO:0034728 | nucleosome organization(GO:0034728) |
0.1 | 0.3 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.1 | 0.2 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.1 | 0.2 | GO:0035121 | obsolete tail morphogenesis(GO:0035121) |
0.1 | 0.4 | GO:0042987 | amyloid precursor protein catabolic process(GO:0042987) |
0.1 | 0.7 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.1 | 0.6 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.1 | 0.2 | GO:0060526 | prostate glandular acinus development(GO:0060525) prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.1 | 0.1 | GO:0044764 | multi-organism cellular process(GO:0044764) |
0.1 | 0.3 | GO:0032204 | regulation of telomere maintenance(GO:0032204) |
0.1 | 0.3 | GO:0009191 | nucleoside diphosphate catabolic process(GO:0009134) ribonucleoside diphosphate catabolic process(GO:0009191) |
0.1 | 0.1 | GO:0051904 | melanosome transport(GO:0032402) pigment granule transport(GO:0051904) |
0.1 | 1.3 | GO:0051402 | neuron apoptotic process(GO:0051402) |
0.1 | 0.2 | GO:0072079 | nephron tubule formation(GO:0072079) |
0.1 | 10.2 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.1 | 0.1 | GO:0048617 | embryonic foregut morphogenesis(GO:0048617) |
0.1 | 0.4 | GO:0055007 | cardiac muscle cell differentiation(GO:0055007) |
0.1 | 0.1 | GO:0030916 | otic vesicle formation(GO:0030916) otic vesicle development(GO:0071599) otic vesicle morphogenesis(GO:0071600) |
0.1 | 0.2 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.1 | 25.5 | GO:0043043 | peptide biosynthetic process(GO:0043043) |
0.1 | 12.3 | GO:0051056 | regulation of small GTPase mediated signal transduction(GO:0051056) |
0.1 | 0.4 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.1 | 0.3 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 1.9 | GO:0006112 | energy reserve metabolic process(GO:0006112) |
0.1 | 0.2 | GO:0045768 | obsolete positive regulation of anti-apoptosis(GO:0045768) |
0.1 | 0.5 | GO:0009268 | response to pH(GO:0009268) |
0.1 | 0.3 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.1 | 2.1 | GO:0006310 | DNA recombination(GO:0006310) |
0.1 | 1.7 | GO:0006641 | triglyceride metabolic process(GO:0006641) |
0.1 | 0.1 | GO:0021533 | cell differentiation in hindbrain(GO:0021533) |
0.1 | 0.2 | GO:0051917 | regulation of fibrinolysis(GO:0051917) |
0.1 | 0.4 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.1 | 0.5 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
0.1 | 2.6 | GO:0006260 | DNA replication(GO:0006260) |
0.1 | 0.2 | GO:0042129 | regulation of T cell proliferation(GO:0042129) |
0.1 | 0.2 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.1 | 0.3 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.1 | 0.1 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
0.1 | 0.8 | GO:0031018 | endocrine pancreas development(GO:0031018) |
0.1 | 0.7 | GO:0046785 | microtubule polymerization(GO:0046785) |
0.1 | 0.2 | GO:0006040 | amino sugar metabolic process(GO:0006040) |
0.1 | 0.1 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.1 | 0.5 | GO:0015695 | organic cation transport(GO:0015695) |
0.1 | 3.8 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
0.1 | 1.2 | GO:0006612 | protein targeting to membrane(GO:0006612) |
0.1 | 1.1 | GO:0007126 | meiotic nuclear division(GO:0007126) |
0.1 | 0.2 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 0.2 | GO:0015838 | quaternary ammonium group transport(GO:0015697) amino-acid betaine transport(GO:0015838) carnitine transport(GO:0015879) |
0.1 | 0.1 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.1 | 0.2 | GO:0008105 | asymmetric protein localization(GO:0008105) |
0.1 | 0.1 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
0.1 | 1.3 | GO:0051925 | obsolete regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051925) |
0.1 | 0.1 | GO:0006907 | pinocytosis(GO:0006907) |
0.1 | 0.2 | GO:0021548 | pons development(GO:0021548) |
0.1 | 0.3 | GO:0006997 | nucleus organization(GO:0006997) |
0.1 | 0.1 | GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
0.1 | 0.2 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.1 | 2.8 | GO:0009615 | response to virus(GO:0009615) |
0.1 | 1.9 | GO:0006914 | autophagy(GO:0006914) |
0.1 | 0.1 | GO:0060013 | righting reflex(GO:0060013) |
0.1 | 0.1 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
0.1 | 6.0 | GO:0044419 | interspecies interaction between organisms(GO:0044419) |
0.1 | 0.1 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 0.6 | GO:0006302 | double-strand break repair(GO:0006302) |
0.1 | 6.0 | GO:0006814 | sodium ion transport(GO:0006814) |
0.1 | 0.4 | GO:0035967 | cellular response to topologically incorrect protein(GO:0035967) |
0.1 | 0.2 | GO:0018410 | C-terminal protein amino acid modification(GO:0018410) |
0.1 | 0.4 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.1 | 0.1 | GO:0045010 | actin nucleation(GO:0045010) |
0.1 | 2.6 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.1 | 0.8 | GO:0007281 | germ cell development(GO:0007281) |
0.1 | 4.2 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.1 | 0.3 | GO:0014047 | glutamate secretion(GO:0014047) |
0.1 | 0.3 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.1 | 0.2 | GO:0019236 | response to pheromone(GO:0019236) |
0.1 | 0.2 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 0.5 | GO:0030307 | positive regulation of cell growth(GO:0030307) |
0.1 | 0.3 | GO:0048753 | pigment granule organization(GO:0048753) |
0.1 | 0.3 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) |
0.1 | 1.1 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.1 | 2.4 | GO:0016071 | mRNA metabolic process(GO:0016071) |
0.1 | 0.1 | GO:0009067 | aspartate family amino acid biosynthetic process(GO:0009067) |
0.1 | 0.7 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.1 | 0.3 | GO:0046039 | GTP metabolic process(GO:0046039) |
0.1 | 0.1 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.1 | 0.1 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
0.1 | 0.1 | GO:0001820 | serotonin secretion(GO:0001820) |
0.1 | 0.1 | GO:0042537 | benzene-containing compound metabolic process(GO:0042537) |
0.1 | 5.6 | GO:0016568 | chromatin modification(GO:0016568) |
0.1 | 0.3 | GO:0070489 | T cell activation(GO:0042110) leukocyte aggregation(GO:0070486) T cell aggregation(GO:0070489) lymphocyte aggregation(GO:0071593) |
0.1 | 0.1 | GO:0002228 | natural killer cell mediated immunity(GO:0002228) natural killer cell mediated cytotoxicity(GO:0042267) |
0.1 | 0.1 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.1 | 0.7 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 0.8 | GO:0042326 | negative regulation of phosphorylation(GO:0042326) |
0.1 | 0.2 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.1 | 0.1 | GO:0030104 | water homeostasis(GO:0030104) |
0.1 | 0.5 | GO:0006555 | methionine metabolic process(GO:0006555) |
0.1 | 0.2 | GO:0000723 | telomere maintenance(GO:0000723) |
0.1 | 0.5 | GO:0007632 | visual behavior(GO:0007632) |
0.1 | 0.1 | GO:0032611 | interleukin-1 beta production(GO:0032611) interleukin-1 production(GO:0032612) |
0.1 | 0.2 | GO:0007215 | glutamate receptor signaling pathway(GO:0007215) |
0.1 | 0.1 | GO:0031334 | positive regulation of protein complex assembly(GO:0031334) |
0.1 | 0.3 | GO:0030183 | B cell differentiation(GO:0030183) |
0.1 | 0.2 | GO:0006301 | postreplication repair(GO:0006301) |
0.1 | 0.3 | GO:0030534 | adult behavior(GO:0030534) |
0.1 | 0.4 | GO:0060678 | dichotomous subdivision of terminal units involved in ureteric bud branching(GO:0060678) |
0.1 | 0.3 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
0.1 | 0.1 | GO:0050706 | regulation of interleukin-1 beta secretion(GO:0050706) |
0.1 | 0.5 | GO:0019319 | hexose biosynthetic process(GO:0019319) |
0.1 | 0.8 | GO:0008286 | insulin receptor signaling pathway(GO:0008286) |
0.1 | 0.1 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.1 | 0.1 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
0.1 | 0.4 | GO:1904029 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) regulation of cyclin-dependent protein kinase activity(GO:1904029) |
0.1 | 0.2 | GO:0006390 | mitochondrial RNA metabolic process(GO:0000959) transcription from mitochondrial promoter(GO:0006390) |
0.1 | 0.1 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.1 | 0.1 | GO:0006479 | protein methylation(GO:0006479) protein alkylation(GO:0008213) |
0.1 | 0.5 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.1 | 0.1 | GO:0006972 | hyperosmotic response(GO:0006972) |
0.1 | 0.1 | GO:0031000 | response to caffeine(GO:0031000) |
0.1 | 0.5 | GO:0051149 | positive regulation of muscle cell differentiation(GO:0051149) |
0.1 | 0.6 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.1 | 0.1 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.0 | 0.0 | GO:0002021 | response to dietary excess(GO:0002021) |
0.0 | 0.0 | GO:0043271 | negative regulation of ion transport(GO:0043271) |
0.0 | 0.1 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.0 | 0.1 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.0 | 0.5 | GO:0043269 | regulation of ion transport(GO:0043269) |
0.0 | 1.0 | GO:0061025 | membrane fusion(GO:0061025) |
0.0 | 0.1 | GO:0001906 | cell killing(GO:0001906) |
0.0 | 0.0 | GO:0033108 | mitochondrial respiratory chain complex assembly(GO:0033108) |
0.0 | 0.1 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.0 | 0.1 | GO:0002685 | regulation of leukocyte migration(GO:0002685) |
0.0 | 0.4 | GO:0009408 | response to heat(GO:0009408) |
0.0 | 0.1 | GO:0043536 | positive regulation of blood vessel endothelial cell migration(GO:0043536) |
0.0 | 0.0 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.0 | 0.2 | GO:0045666 | positive regulation of neuron differentiation(GO:0045666) |
0.0 | 0.3 | GO:0010212 | response to ionizing radiation(GO:0010212) |
0.0 | 0.2 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.0 | 0.4 | GO:0043687 | post-translational protein modification(GO:0043687) |
0.0 | 6.4 | GO:0007186 | G-protein coupled receptor signaling pathway(GO:0007186) |
0.0 | 0.0 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.0 | 0.0 | GO:0015810 | C4-dicarboxylate transport(GO:0015740) aspartate transport(GO:0015810) |
0.0 | 0.2 | GO:0006882 | cellular zinc ion homeostasis(GO:0006882) zinc ion homeostasis(GO:0055069) |
0.0 | 0.1 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.0 | 0.0 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.0 | 0.1 | GO:0046101 | hypoxanthine biosynthetic process(GO:0046101) |
0.0 | 0.1 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.0 | 0.2 | GO:0019359 | nicotinamide nucleotide biosynthetic process(GO:0019359) |
0.0 | 0.1 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.0 | 2.8 | GO:0051603 | proteolysis involved in cellular protein catabolic process(GO:0051603) |
0.0 | 0.1 | GO:0030279 | negative regulation of ossification(GO:0030279) |
0.0 | 0.2 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
0.0 | 0.1 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.0 | 0.8 | GO:0007204 | positive regulation of cytosolic calcium ion concentration(GO:0007204) |
0.0 | 0.1 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.0 | 0.1 | GO:0048588 | developmental cell growth(GO:0048588) |
0.0 | 0.1 | GO:0043248 | proteasome assembly(GO:0043248) |
0.0 | 0.0 | GO:1902692 | regulation of neuroblast proliferation(GO:1902692) |
0.0 | 0.2 | GO:0071166 | ribonucleoprotein complex localization(GO:0071166) |
0.0 | 0.1 | GO:0070989 | oxidative demethylation(GO:0070989) |
0.0 | 10.9 | GO:0015031 | protein transport(GO:0015031) |
0.0 | 0.1 | GO:0042737 | drug catabolic process(GO:0042737) |
0.0 | 0.1 | GO:0051310 | mitotic metaphase plate congression(GO:0007080) metaphase plate congression(GO:0051310) |
0.0 | 34.3 | GO:0016070 | RNA metabolic process(GO:0016070) |
0.0 | 0.2 | GO:0045995 | regulation of embryonic development(GO:0045995) |
0.0 | 0.1 | GO:0044245 | polysaccharide digestion(GO:0044245) |
0.0 | 0.0 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.0 | 0.2 | GO:0048863 | stem cell differentiation(GO:0048863) |
0.0 | 0.5 | GO:0008643 | carbohydrate transport(GO:0008643) |
0.0 | 0.0 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
0.0 | 0.0 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.0 | 0.0 | GO:0001660 | fever generation(GO:0001660) |
0.0 | 0.0 | GO:0016045 | detection of bacterium(GO:0016045) |
0.0 | 0.1 | GO:0009953 | dorsal/ventral pattern formation(GO:0009953) |
0.0 | 0.1 | GO:0019695 | choline metabolic process(GO:0019695) |
0.0 | 0.0 | GO:0040023 | establishment of nucleus localization(GO:0040023) |
0.0 | 0.1 | GO:0060135 | maternal process involved in female pregnancy(GO:0060135) |
0.0 | 0.0 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
0.0 | 0.0 | GO:1904894 | positive regulation of JAK-STAT cascade(GO:0046427) positive regulation of STAT cascade(GO:1904894) |
0.0 | 0.1 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.0 | 0.9 | GO:0006457 | protein folding(GO:0006457) |
0.0 | 0.1 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.0 | 0.0 | GO:0048385 | regulation of retinoic acid receptor signaling pathway(GO:0048385) |
0.0 | 4.2 | GO:0006508 | proteolysis(GO:0006508) |
0.0 | 0.0 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.0 | 4.9 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.0 | 0.6 | GO:0007018 | microtubule-based movement(GO:0007018) |
0.0 | 0.0 | GO:0006772 | thiamine metabolic process(GO:0006772) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 6.5 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
1.4 | 4.1 | GO:0044462 | external encapsulating structure part(GO:0044462) |
1.1 | 3.4 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
1.1 | 3.3 | GO:0032009 | early phagosome(GO:0032009) |
1.0 | 2.9 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
1.0 | 8.6 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.9 | 4.7 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.9 | 0.9 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.9 | 5.2 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.8 | 5.7 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.8 | 11.2 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.8 | 4.8 | GO:0005883 | neurofilament(GO:0005883) |
0.8 | 0.8 | GO:0005921 | gap junction(GO:0005921) |
0.8 | 3.1 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.8 | 0.8 | GO:0043235 | receptor complex(GO:0043235) |
0.8 | 3.1 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
0.7 | 2.2 | GO:0072487 | MSL complex(GO:0072487) |
0.7 | 2.2 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.7 | 7.2 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.7 | 5.7 | GO:0005861 | troponin complex(GO:0005861) |
0.7 | 2.1 | GO:0070820 | tertiary granule(GO:0070820) |
0.7 | 0.7 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.7 | 2.7 | GO:0005667 | transcription factor complex(GO:0005667) |
0.7 | 4.7 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.6 | 3.2 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.6 | 1.9 | GO:0048475 | membrane coat(GO:0030117) coated membrane(GO:0048475) |
0.6 | 0.6 | GO:0031090 | organelle membrane(GO:0031090) |
0.6 | 4.4 | GO:0098984 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.6 | 2.5 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.6 | 1.3 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.6 | 0.6 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.6 | 2.3 | GO:0005827 | polar microtubule(GO:0005827) |
0.6 | 1.7 | GO:0031904 | endosome lumen(GO:0031904) |
0.6 | 3.4 | GO:0001891 | phagocytic cup(GO:0001891) |
0.6 | 6.2 | GO:0001772 | immunological synapse(GO:0001772) |
0.6 | 2.2 | GO:0043218 | compact myelin(GO:0043218) |
0.5 | 1.6 | GO:0031313 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.5 | 2.2 | GO:0005638 | lamin filament(GO:0005638) |
0.5 | 4.8 | GO:0043209 | myelin sheath(GO:0043209) |
0.5 | 4.8 | GO:0000109 | nucleotide-excision repair complex(GO:0000109) |
0.5 | 0.5 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.5 | 1.0 | GO:0031932 | TORC2 complex(GO:0031932) |
0.5 | 10.8 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.5 | 3.1 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.5 | 1.0 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.5 | 2.5 | GO:0005694 | chromosome(GO:0005694) |
0.5 | 1.0 | GO:0032059 | bleb(GO:0032059) |
0.5 | 1.5 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.5 | 1.4 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.5 | 3.4 | GO:0034451 | centriolar satellite(GO:0034451) |
0.5 | 3.8 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.5 | 5.2 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.5 | 3.3 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.5 | 1.4 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.5 | 1.4 | GO:0016939 | kinesin II complex(GO:0016939) |
0.4 | 9.2 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.4 | 1.7 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.4 | 1.2 | GO:0031501 | mannosyltransferase complex(GO:0031501) dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.4 | 6.8 | GO:0030530 | obsolete heterogeneous nuclear ribonucleoprotein complex(GO:0030530) |
0.4 | 2.4 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.4 | 1.2 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.4 | 0.4 | GO:0031430 | M band(GO:0031430) |
0.4 | 1.5 | GO:0070552 | BRISC complex(GO:0070552) |
0.4 | 2.2 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.4 | 0.4 | GO:0033643 | host(GO:0018995) host cell part(GO:0033643) host intracellular part(GO:0033646) intracellular region of host(GO:0043656) host cell(GO:0043657) other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.4 | 1.4 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.4 | 1.1 | GO:0001940 | male pronucleus(GO:0001940) |
0.4 | 0.4 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.3 | 1.4 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.3 | 1.4 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.3 | 2.4 | GO:0000346 | transcription export complex(GO:0000346) |
0.3 | 1.4 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.3 | 3.1 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.3 | 1.4 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.3 | 1.0 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.3 | 3.0 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.3 | 6.7 | GO:0031519 | PcG protein complex(GO:0031519) |
0.3 | 1.0 | GO:1903561 | extracellular exosome(GO:0070062) extracellular vesicle(GO:1903561) |
0.3 | 2.0 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.3 | 1.0 | GO:0000124 | SAGA complex(GO:0000124) |
0.3 | 2.0 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.3 | 0.3 | GO:0005839 | proteasome core complex(GO:0005839) |
0.3 | 1.0 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.3 | 0.3 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.3 | 4.4 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.3 | 3.1 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.3 | 2.2 | GO:0005916 | fascia adherens(GO:0005916) |
0.3 | 2.8 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.3 | 1.2 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.3 | 1.5 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.3 | 1.5 | GO:0032590 | dendrite membrane(GO:0032590) |
0.3 | 5.8 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.3 | 0.6 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.3 | 0.9 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.3 | 1.5 | GO:0000791 | euchromatin(GO:0000791) |
0.3 | 0.9 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.3 | 7.3 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.3 | 2.9 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.3 | 1.7 | GO:0042382 | paraspeckles(GO:0042382) |
0.3 | 2.0 | GO:0031256 | leading edge membrane(GO:0031256) |
0.3 | 23.5 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.3 | 4.8 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.3 | 2.3 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.3 | 0.8 | GO:0034464 | BBSome(GO:0034464) |
0.3 | 0.6 | GO:0030897 | HOPS complex(GO:0030897) |
0.3 | 4.5 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.3 | 9.2 | GO:0030175 | filopodium(GO:0030175) |
0.3 | 0.8 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.3 | 5.8 | GO:0005776 | autophagosome(GO:0005776) |
0.3 | 31.7 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.3 | 1.4 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.3 | 4.6 | GO:0005844 | polysome(GO:0005844) |
0.3 | 5.7 | GO:0032155 | cell division site(GO:0032153) cell division site part(GO:0032155) |
0.3 | 1.1 | GO:0016589 | NURF complex(GO:0016589) |
0.3 | 1.1 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.3 | 3.7 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.3 | 0.5 | GO:0044291 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
0.3 | 2.1 | GO:0005884 | actin filament(GO:0005884) |
0.3 | 1.8 | GO:0030681 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.3 | 0.8 | GO:0000299 | obsolete integral to membrane of membrane fraction(GO:0000299) |
0.3 | 1.3 | GO:0042588 | zymogen granule(GO:0042588) |
0.3 | 1.8 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.3 | 0.5 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.3 | 1.8 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.3 | 1.3 | GO:0030315 | T-tubule(GO:0030315) |
0.3 | 1.5 | GO:0070822 | Sin3 complex(GO:0016580) Sin3-type complex(GO:0070822) |
0.3 | 5.0 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.2 | 15.7 | GO:0030027 | lamellipodium(GO:0030027) |
0.2 | 3.2 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.2 | 2.0 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.2 | 0.5 | GO:0005792 | obsolete microsome(GO:0005792) |
0.2 | 1.5 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.2 | 1.7 | GO:0042598 | obsolete vesicular fraction(GO:0042598) |
0.2 | 0.7 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.2 | 0.5 | GO:0042584 | chromaffin granule(GO:0042583) chromaffin granule membrane(GO:0042584) |
0.2 | 1.4 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.2 | 0.5 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.2 | 1.7 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.2 | 10.2 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.2 | 12.8 | GO:0005643 | nuclear pore(GO:0005643) |
0.2 | 0.7 | GO:0071986 | Ragulator complex(GO:0071986) |
0.2 | 7.7 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.2 | 0.5 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.2 | 0.2 | GO:0000407 | pre-autophagosomal structure(GO:0000407) pre-autophagosomal structure membrane(GO:0034045) |
0.2 | 1.4 | GO:0061200 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
0.2 | 0.5 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.2 | 0.2 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.2 | 1.8 | GO:0000242 | pericentriolar material(GO:0000242) |
0.2 | 3.9 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.2 | 1.4 | GO:0044304 | main axon(GO:0044304) |
0.2 | 0.9 | GO:0097526 | U4/U6 x U5 tri-snRNP complex(GO:0046540) spliceosomal tri-snRNP complex(GO:0097526) |
0.2 | 0.4 | GO:0002139 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
0.2 | 2.9 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.2 | 1.9 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.2 | 0.6 | GO:0031083 | BLOC complex(GO:0031082) BLOC-1 complex(GO:0031083) |
0.2 | 0.4 | GO:0000800 | lateral element(GO:0000800) |
0.2 | 0.6 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.2 | 6.2 | GO:0005876 | spindle microtubule(GO:0005876) |
0.2 | 1.7 | GO:0005774 | vacuolar membrane(GO:0005774) |
0.2 | 1.0 | GO:0045179 | apical cortex(GO:0045179) |
0.2 | 10.2 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.2 | 0.8 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.2 | 10.4 | GO:0012506 | vesicle membrane(GO:0012506) |
0.2 | 2.3 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.2 | 0.6 | GO:0045298 | tubulin complex(GO:0045298) |
0.2 | 1.9 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.2 | 0.8 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.2 | 0.6 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.2 | 3.4 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.2 | 1.0 | GO:0000805 | X chromosome(GO:0000805) |
0.2 | 2.0 | GO:0071203 | WASH complex(GO:0071203) |
0.2 | 0.6 | GO:0031528 | microvillus membrane(GO:0031528) |
0.2 | 2.0 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.2 | 0.2 | GO:0033270 | paranode region of axon(GO:0033270) |
0.2 | 5.3 | GO:0031902 | late endosome membrane(GO:0031902) |
0.2 | 7.3 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.2 | 3.5 | GO:0000502 | proteasome complex(GO:0000502) |
0.2 | 1.2 | GO:0005683 | U7 snRNP(GO:0005683) |
0.2 | 1.1 | GO:0051233 | spindle midzone(GO:0051233) |
0.2 | 0.8 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.2 | 9.3 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.2 | 0.9 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.2 | 0.4 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.2 | 0.9 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.2 | 2.6 | GO:0043195 | terminal bouton(GO:0043195) |
0.2 | 0.6 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.2 | 0.4 | GO:0001950 | obsolete plasma membrane enriched fraction(GO:0001950) |
0.2 | 17.0 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.2 | 2.8 | GO:0008305 | integrin complex(GO:0008305) protein complex involved in cell adhesion(GO:0098636) |
0.2 | 5.4 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.2 | 1.1 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.2 | 0.7 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.2 | 0.7 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.2 | 2.7 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.2 | 1.8 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.2 | 2.9 | GO:0032420 | stereocilium(GO:0032420) |
0.2 | 2.9 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.2 | 0.7 | GO:0032156 | septin complex(GO:0031105) septin cytoskeleton(GO:0032156) |
0.2 | 6.9 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.2 | 0.9 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.2 | 3.0 | GO:0035097 | methyltransferase complex(GO:0034708) histone methyltransferase complex(GO:0035097) |
0.2 | 0.5 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.2 | 4.3 | GO:0005626 | obsolete insoluble fraction(GO:0005626) |
0.2 | 1.9 | GO:0098802 | plasma membrane receptor complex(GO:0098802) |
0.2 | 1.4 | GO:0070652 | HAUS complex(GO:0070652) |
0.2 | 4.1 | GO:0031526 | brush border membrane(GO:0031526) |
0.2 | 0.7 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.2 | 0.2 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.2 | 11.4 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.2 | 0.3 | GO:0030904 | retromer complex(GO:0030904) |
0.2 | 13.8 | GO:0005819 | spindle(GO:0005819) |
0.2 | 3.5 | GO:0032587 | ruffle membrane(GO:0032587) |
0.2 | 15.1 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.2 | 0.3 | GO:0031931 | TORC1 complex(GO:0031931) |
0.2 | 0.5 | GO:0070188 | obsolete Stn1-Ten1 complex(GO:0070188) |
0.2 | 1.8 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.2 | 0.8 | GO:0030426 | growth cone(GO:0030426) site of polarized growth(GO:0030427) |
0.2 | 1.9 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.2 | 2.9 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
0.2 | 2.2 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.2 | 0.6 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
0.2 | 0.3 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.2 | 37.6 | GO:0005768 | endosome(GO:0005768) |
0.2 | 29.2 | GO:0005625 | obsolete soluble fraction(GO:0005625) |
0.2 | 0.8 | GO:0000796 | condensin complex(GO:0000796) |
0.2 | 0.5 | GO:0005915 | zonula adherens(GO:0005915) |
0.2 | 2.1 | GO:0046930 | pore complex(GO:0046930) |
0.2 | 0.3 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.2 | 0.8 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 0.1 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 1.9 | GO:0070461 | SAGA-type complex(GO:0070461) |
0.1 | 9.0 | GO:0019717 | obsolete synaptosome(GO:0019717) |
0.1 | 0.7 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.1 | 0.4 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.1 | 4.5 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 0.6 | GO:0016585 | obsolete chromatin remodeling complex(GO:0016585) |
0.1 | 0.4 | GO:0042825 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
0.1 | 1.0 | GO:0005840 | ribosome(GO:0005840) |
0.1 | 0.3 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 0.6 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.1 | 0.1 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 12.6 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 0.9 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 2.8 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.1 | 3.2 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.1 | 2.6 | GO:0044798 | nuclear transcription factor complex(GO:0044798) |
0.1 | 0.8 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 1.6 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.1 | 3.9 | GO:0000776 | kinetochore(GO:0000776) |
0.1 | 3.9 | GO:0036064 | ciliary basal body(GO:0036064) |
0.1 | 0.3 | GO:0042599 | lamellar body(GO:0042599) |
0.1 | 0.9 | GO:0042612 | MHC protein complex(GO:0042611) MHC class I protein complex(GO:0042612) |
0.1 | 1.4 | GO:0005814 | centriole(GO:0005814) |
0.1 | 0.6 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.1 | 0.5 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 515.4 | GO:0005634 | nucleus(GO:0005634) |
0.1 | 1.4 | GO:0019861 | obsolete flagellum(GO:0019861) |
0.1 | 0.9 | GO:0031201 | SNARE complex(GO:0031201) |
0.1 | 4.6 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.1 | 1.2 | GO:0031513 | nonmotile primary cilium(GO:0031513) |
0.1 | 1.1 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 7.8 | GO:0019867 | outer membrane(GO:0019867) |
0.1 | 3.1 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.1 | 60.6 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.1 | 1.5 | GO:0030018 | Z disc(GO:0030018) |
0.1 | 47.9 | GO:0005794 | Golgi apparatus(GO:0005794) |
0.1 | 3.3 | GO:0000313 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.1 | 73.9 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 0.1 | GO:0097458 | neuron part(GO:0097458) |
0.1 | 3.2 | GO:0030424 | axon(GO:0030424) |
0.1 | 4.8 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 0.1 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 1.4 | GO:0034358 | protein-lipid complex(GO:0032994) plasma lipoprotein particle(GO:0034358) lipoprotein particle(GO:1990777) |
0.1 | 2.2 | GO:0034707 | chloride channel complex(GO:0034707) |
0.1 | 65.9 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.1 | 2.0 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.1 | 0.3 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 0.1 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 0.3 | GO:0016234 | inclusion body(GO:0016234) |
0.1 | 0.5 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 0.8 | GO:1990904 | intracellular ribonucleoprotein complex(GO:0030529) ribonucleoprotein complex(GO:1990904) |
0.1 | 169.3 | GO:0016021 | integral component of membrane(GO:0016021) |
0.1 | 0.3 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.1 | 0.2 | GO:0033150 | cytoskeletal calyx(GO:0033150) |
0.1 | 37.9 | GO:0005829 | cytosol(GO:0005829) |
0.1 | 0.1 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.1 | 0.1 | GO:0042581 | specific granule(GO:0042581) |
0.1 | 0.1 | GO:0030496 | midbody(GO:0030496) |
0.1 | 0.3 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.1 | 1.0 | GO:0005929 | cilium(GO:0005929) |
0.0 | 0.2 | GO:0001726 | ruffle(GO:0001726) |
0.0 | 0.8 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.0 | 0.3 | GO:0043005 | neuron projection(GO:0043005) |
0.0 | 0.0 | GO:0033011 | perinuclear theca(GO:0033011) |
0.0 | 0.1 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.0 | 0.1 | GO:0031982 | vesicle(GO:0031982) |
0.0 | 0.0 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.0 | 0.0 | GO:0070695 | FHF complex(GO:0070695) |
0.0 | 4.8 | GO:0005886 | plasma membrane(GO:0005886) |
0.0 | 0.1 | GO:0097223 | sperm part(GO:0097223) |
0.0 | 21.1 | GO:0005622 | intracellular(GO:0005622) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 5.0 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
1.7 | 5.0 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
1.5 | 6.1 | GO:0031014 | troponin T binding(GO:0031014) |
1.5 | 4.4 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
1.5 | 17.4 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) |
1.4 | 4.2 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
1.4 | 4.1 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
1.2 | 6.0 | GO:0052813 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
1.2 | 4.8 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
1.1 | 6.8 | GO:0001727 | lipid kinase activity(GO:0001727) |
1.1 | 1.1 | GO:0033691 | sialic acid binding(GO:0033691) |
1.1 | 8.7 | GO:0050700 | CARD domain binding(GO:0050700) |
1.0 | 3.1 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
1.0 | 3.1 | GO:0004476 | mannose-6-phosphate isomerase activity(GO:0004476) |
1.0 | 3.1 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
1.0 | 3.0 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
1.0 | 4.0 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
1.0 | 2.9 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
1.0 | 1.9 | GO:0052659 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity(GO:0052659) |
0.9 | 2.8 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.9 | 3.8 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.9 | 2.8 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.9 | 2.8 | GO:0035197 | siRNA binding(GO:0035197) |
0.9 | 5.4 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.9 | 2.7 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.9 | 5.4 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.9 | 4.4 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.9 | 2.6 | GO:0050693 | LBD domain binding(GO:0050693) |
0.9 | 2.6 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.9 | 0.9 | GO:0046030 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) inositol trisphosphate phosphatase activity(GO:0046030) |
0.9 | 3.4 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.8 | 3.4 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.8 | 6.7 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.8 | 8.4 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.8 | 2.5 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.8 | 13.7 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.8 | 6.4 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.8 | 3.1 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.8 | 0.8 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.7 | 4.5 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.7 | 3.7 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.7 | 1.5 | GO:0000247 | C-8 sterol isomerase activity(GO:0000247) |
0.7 | 5.1 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.7 | 1.4 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.7 | 2.9 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.7 | 4.3 | GO:0016208 | AMP binding(GO:0016208) |
0.7 | 2.1 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.7 | 4.8 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.7 | 2.7 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) |
0.7 | 2.0 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.7 | 4.6 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.7 | 3.3 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.7 | 2.6 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.7 | 3.3 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.7 | 2.0 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.7 | 1.3 | GO:0005123 | death receptor binding(GO:0005123) |
0.6 | 7.8 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.6 | 5.8 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.6 | 2.6 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.6 | 22.9 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.6 | 2.5 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.6 | 1.9 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.6 | 6.3 | GO:0003709 | obsolete RNA polymerase III transcription factor activity(GO:0003709) |
0.6 | 1.9 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.6 | 1.9 | GO:0005113 | patched binding(GO:0005113) |
0.6 | 1.9 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.6 | 3.1 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.6 | 1.2 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.6 | 1.2 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.6 | 4.3 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.6 | 2.4 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.6 | 1.8 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.6 | 0.6 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.6 | 1.2 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.6 | 1.8 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.6 | 1.2 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.6 | 2.9 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.6 | 2.9 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.6 | 1.7 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.6 | 1.7 | GO:0004500 | dopamine beta-monooxygenase activity(GO:0004500) |
0.6 | 6.3 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.6 | 5.7 | GO:0030276 | clathrin binding(GO:0030276) |
0.6 | 26.4 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.6 | 0.6 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.6 | 8.9 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.6 | 2.2 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.6 | 2.2 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.5 | 2.2 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.5 | 0.5 | GO:0005035 | death receptor activity(GO:0005035) |
0.5 | 2.2 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.5 | 4.4 | GO:0005522 | profilin binding(GO:0005522) |
0.5 | 8.7 | GO:0043621 | protein self-association(GO:0043621) |
0.5 | 2.7 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.5 | 3.3 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.5 | 1.6 | GO:0051425 | PTB domain binding(GO:0051425) |
0.5 | 2.7 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.5 | 2.7 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.5 | 1.6 | GO:0030343 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.5 | 2.6 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.5 | 1.6 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.5 | 3.1 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.5 | 0.5 | GO:0003896 | DNA primase activity(GO:0003896) |
0.5 | 1.0 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.5 | 2.1 | GO:0048495 | Roundabout binding(GO:0048495) |
0.5 | 6.2 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.5 | 1.0 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.5 | 0.5 | GO:0004516 | nicotinate phosphoribosyltransferase activity(GO:0004516) |
0.5 | 1.5 | GO:0055106 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.5 | 1.0 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.5 | 18.5 | GO:0001948 | glycoprotein binding(GO:0001948) |
0.5 | 2.0 | GO:0015925 | galactosidase activity(GO:0015925) |
0.5 | 2.5 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.5 | 2.0 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
0.5 | 9.8 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.5 | 5.8 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.5 | 2.9 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.5 | 1.4 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.5 | 4.3 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.5 | 8.5 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.5 | 1.4 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.5 | 1.4 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.5 | 2.3 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.5 | 1.4 | GO:0048156 | tau protein binding(GO:0048156) |
0.5 | 2.3 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.5 | 1.4 | GO:0043398 | HLH domain binding(GO:0043398) |
0.5 | 3.2 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.5 | 2.3 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.5 | 1.4 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.5 | 2.3 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.5 | 1.8 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.4 | 2.7 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.4 | 0.9 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.4 | 4.9 | GO:0030553 | cGMP binding(GO:0030553) |
0.4 | 1.3 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.4 | 1.3 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.4 | 1.3 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.4 | 3.1 | GO:0005112 | Notch binding(GO:0005112) |
0.4 | 7.9 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.4 | 1.3 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.4 | 1.7 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.4 | 1.3 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.4 | 5.6 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.4 | 1.3 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.4 | 0.4 | GO:0019902 | phosphatase binding(GO:0019902) |
0.4 | 2.5 | GO:0001012 | RNA polymerase II regulatory region sequence-specific DNA binding(GO:0000977) RNA polymerase II regulatory region DNA binding(GO:0001012) |
0.4 | 1.3 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.4 | 1.7 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.4 | 1.7 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.4 | 0.8 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.4 | 1.7 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
0.4 | 1.2 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.4 | 4.6 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.4 | 1.2 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.4 | 2.9 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.4 | 1.2 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.4 | 1.2 | GO:1990939 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) ATP-dependent microtubule motor activity(GO:1990939) |
0.4 | 2.5 | GO:0070513 | death domain binding(GO:0070513) |
0.4 | 1.2 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.4 | 1.2 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.4 | 4.1 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.4 | 1.6 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.4 | 1.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.4 | 4.8 | GO:0008556 | potassium-transporting ATPase activity(GO:0008556) |
0.4 | 1.2 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
0.4 | 2.8 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.4 | 2.4 | GO:0004950 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.4 | 2.0 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.4 | 2.4 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.4 | 0.4 | GO:0015205 | nucleobase transmembrane transporter activity(GO:0015205) |
0.4 | 1.6 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.4 | 1.9 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.4 | 1.6 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.4 | 1.6 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.4 | 1.6 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.4 | 0.8 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.4 | 5.0 | GO:0043499 | obsolete eukaryotic cell surface binding(GO:0043499) |
0.4 | 1.1 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.4 | 1.5 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.4 | 0.8 | GO:0019956 | chemokine binding(GO:0019956) |
0.4 | 1.1 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.4 | 1.1 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.4 | 0.4 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.4 | 1.9 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.4 | 3.0 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.4 | 1.1 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |